0001755672-21-000027 | 10-Q | XBRL Viewer

Provision for (benefit from) Deferred Income Tax

Net income

$ 1,608

$ 658

151

(153)

Net Periodic Pension and OPEB benefit, net

(959)

(255)

Pension and OPEB Contributions

(202)

(222)

Net loss (gain) on sales of property, businesses, consolidated companies, and investments

(1)

Accounts and notes receivable

261

298

Other net loss

117

240

(1,116)

(619)

Inventories

375

481

Accounts Payable

(41)

(629)

Other Assets and Liabilities

(1,945)

(2,169)

236

Cash used for operating activities

(819)

(1,237)

Cash used for investing activities

Capital expenditures

(413)

(301)

Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested

Investments in and loans to nonconsolidated affiliates

(3)

(1)

Purchases of investments

(147)

(656)

Proceeds from Sale and Maturities of Investments

310

498

Other investing activities - net

(1)

(7)

Cash used for investing activities

(201)

(445)

Cash provided by financing activities

Net change in borrowings (less than 90 days)

949

1,582

Proceeds from debt

419

2,434

Payments on Debt

(1)

(879)

Repurchase of Common Stock

(750)

(83)

Proceeds from Exercise of Stock Options

Dividends paid to stockholders

(295)

(291)

Payments for acquisition of subsidiary's interest from the non-controlling Interests

(60)

Other financing activities

(28)

(27)

Cash provided by financing activities

365

2,695

Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash

(78)

(64)

Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash

(733)

949

Cash, Cash Equivalents and Restricted Cash at Beginning of Period

3,873

2,173

Cash, Cash Equivalents and Restricted Cash at End of Period

^[1]

3,140

3,122

Net income

1,578

596

Provision for (benefit from) Deferred Income Tax

926

868

151

(153)

Net Periodic Pension and OPEB benefit, net

(959)

(255)

Pension and OPEB Contributions

(202)

(222)

Net loss (gain) on sales of property, businesses, consolidated companies, and investments

(1)

Accounts and notes receivable

261

298

Other net loss

117

240

(1,116)

(619)

Inventories

375

481

Accounts Payable

(41)

(629)

Other Assets and Liabilities

(1,945)

(2,169)

252

Cash used for operating activities

(838)

(1,283)

Cash used for investing activities

Capital expenditures

(413)

(301)

Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested

Investments in and loans to nonconsolidated affiliates

(3)

(1)

Purchases of investments

(147)

(656)

Proceeds from Sale and Maturities of Investments

310

498

Other investing activities - net

(1)

(7)

Cash used for investing activities

(201)

(445)

Cash provided by financing activities

Net change in borrowings (less than 90 days)

949

1,582

Proceeds from Related Party Debt

Repayments of Related Party Debt

(1,047)

(376)

Proceeds from debt

419

2,434

Payments on Debt

(1)

(879)

Proceeds from Exercise of Stock Options

Payments for acquisition of subsidiary's interest from the non-controlling Interests

(60)

Other financing activities

(38)

(46)

Cash provided by financing activities

384

2,741

Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash

(78)

(64)

Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash

(733)

949

Cash, Cash Equivalents and Restricted Cash at Beginning of Period

3,873

2,173

Cash, Cash Equivalents and Restricted Cash at End of Period

3,140

3,122

Total company [Member]

926

868

Total company [Member] | EID [Member]

261

298

926

868

$ 261

$ 298

[1]	See page 17 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in interim Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows.

Statement of Stockholders Equity Statement - USD ($) $ in Millions	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comp (Loss) Income	Noncontrolling Interest [Member]	EID [Member]	EID [Member] Preferred Stock [Member]	EID [Member] Common Stock [Member]	EID [Member] Additional Paid-in Capital [Member]	EID [Member] Retained Earnings [Member]	EID [Member] Accumulated Other Comp (Loss) Income	EID [Member] Noncontrolling Interest [Member]
Beginning Balance at Dec. 31, 2019	$ 24,555	$ 7	$ 27,997	$ (425)	$ (3,270)	$ 246	$ 20,528	$ 239	$ 0	$ 23,958	$ (406)	$ (3,270)	$ 7
Net income (loss)	282			272		10	258				250		8
Other comprehensive (loss) income	(663)				(663)		(663)					(663)
Common Dividends	(97)		(97)
Dividends, Preferred Stock							(2)			(2)
Issuance of Corteva Stock	14		14				14			14
Share-based compensation	2		2				2			2
Repurchase of common stock	(50)		(50)
Other-net	36		40	(2)		(2)	30			32	(2)
Ending Balance at Mar. 31, 2020	24,079	7	27,906	(155)	(3,933)	254	20,167	239	0	24,004	(158)	(3,933)	15
Beginning Balance at Dec. 31, 2019	24,555	7	27,997	(425)	(3,270)	246	20,528	239	0	23,958	(406)	(3,270)	7
Net income (loss)	658						596
Other comprehensive (loss) income	(526)				(526)		(526)
Ending Balance at Sep. 30, 2020	24,346	7	27,895	0	(3,796)	240	20,612	239	0	23,995	173	(3,796)	1
Beginning Balance at Mar. 31, 2020	24,079	7	27,906	(155)	(3,933)	254	20,167	239	0	24,004	(158)	(3,933)	15
Net income (loss)	766			760		6	742				739		3
Other comprehensive (loss) income	88				88		88					88
Common Dividends	(97)			(97)
Dividends, Preferred Stock							(3)				(3)
Issuance of Corteva Stock	3		3				3			3
Share-based compensation	19		19				19			19
Acquisition of a noncontrolling interest in consolidated subsidiaries	(52)		(37)			(15)	(52)			(37)			(15)
Other-net	(5)					(5)	(8)			(8)	2		(2)
Ending Balance at Jun. 30, 2020	24,801	7	27,891	508	(3,845)	240	20,956	239	0	23,981	580	(3,845)	1
Net income (loss)	(390)			(392)		2	(404)				(404)
Other comprehensive (loss) income	49				49		49					49
Common Dividends	(97)			(97)
Dividends, Preferred Stock							(2)				(2)
Issuance of Corteva Stock	2		2				2			2
Share-based compensation	15		16	(1)			15			16	(1)
Repurchase of common stock	(33)		(15)	(18)
Other-net	(1)		1			(2)	(4)			(4)
Ending Balance at Sep. 30, 2020	24,346	7	27,895	0	(3,796)	240	20,612	239	0	23,995	173	(3,796)	1
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	3,712						3,712
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	3,857						3,857
Beginning Balance at Dec. 31, 2020	25,063	7	27,707	0	(2,890)	239	21,601	239	0	24,049	203	(2,890)	0
Net income (loss)	603			600		3	592				591		1
Other comprehensive (loss) income	(477)				(477)		(477)					(477)
Common Dividends	(97)		(97)
Dividends, Preferred Stock							(2)				(2)
Issuance of Corteva Stock	38		38				38			38
Repurchase of common stock	(350)		(18)	(332)
Other-net	(2)					(2)	(4)			(4)
Ending Balance at Mar. 31, 2021	24,778	7	27,630	268	(3,367)	240	21,748	239	0	24,083	792	(3,367)	1
Beginning Balance at Dec. 31, 2020	25,063	7	27,707	0	(2,890)	239	21,601	239	0	24,049	203	(2,890)	0
Net income (loss)	1,608						1,578
Other comprehensive (loss) income	(755)				(755)		(755)
Ending Balance at Sep. 30, 2021	24,979	7	27,712	666	(3,645)	239	22,523	239	0	24,158	1,771	(3,645)	0
Beginning Balance at Mar. 31, 2021	24,778	7	27,630	268	(3,367)	240	21,748	239	0	24,083	792	(3,367)	1
Net income (loss)	973			970		3	963				963
Other comprehensive (loss) income	122				122		122					122
Common Dividends	(95)			(95)
Dividends, Preferred Stock							(3)				(3)
Issuance of Corteva Stock	28		28				28			28
Share-based compensation	22		23	(1)			22			23	(1)
Repurchase of common stock	(200)			(200)
Other-net	(3)		1	(1)		(3)	(2)			(3)	1
Ending Balance at Jun. 30, 2021	25,625	7	27,682	941	(3,245)	240	22,878	239	0	24,131	1,752	(3,245)	1
Net income (loss)	32			30		2	23				24		(1)
Other comprehensive (loss) income	(400)				(400)		(400)					(400)
Common Dividends	(103)			(103)
Dividends, Preferred Stock							(2)				(2)
Issuance of Corteva Stock	5		5				5			5
Share-based compensation	25		26	(1)			25			26	(1)
Repurchase of common stock	(200)			(200)
Other-net	(5)		(1)	(1)		(3)	(6)			(4)	(2)
Ending Balance at Sep. 30, 2021	24,979	$ 7	$ 27,712	$ 666	$ (3,645)	$ 239	22,523	$ 239	$ 0	$ 24,158	$ 1,771	$ (3,645)	$ 0
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$ 3,960						$ 3,960

Statement of Stockholders' Equity Parentheticals (Parentheticals) - $ / shares	3 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020
Common Stock, Dividends, Per Share, Declared	$ 0.14	$ 0.13	$ 0.13	$ 0.13	$ 0.13	$ 0.13
EID [Member] \| $4.50 Series Preferred Stock [Member]
Preferred Stock, Dividends Per Share, Declared	1.125	1.125	1.125	1.125	1.125	1.125
EID [Member] \| $3.50 Series Preferred Stock [Member]
Preferred Stock, Dividends Per Share, Declared	$ 0.875	$ 0.875	$ 0.875	$ 0.875	$ 0.875	$ 0.875

Summary of Significant Accounting Policies (Notes)	9 Months Ended
Summary of Significant Accounting Policies (Notes)	Sep. 30, 2021
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited interim Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included. Results for interim periods should not be considered indicative of results for a full year. These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2020, collectively referred to as the “2020 Annual Report.” The interim Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained. Certain reclassifications of prior year's data have been made to conform to current year's presentation. During the first quarter 2020, the company recorded an increase of $40 million to APIC relating to net assets recorded as transferred as part of the 2019 Internal Reorganizations that were retained. Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. Argentina contributes approximately 4 percent to our annual Sales and EBITDA. We remeasure net monetary assets and translate our financial statements utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The ability to draw down Peso cash balances is limited at this time due to government restrictions and market availability of U.S. Dollars. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 6 – Supplementary Information, to the interim Consolidated Financial Statements, and Note 9 – Supplemental Information, to the company's 2020 Annual Report). As of September 30, 2021, a further 10 percent deterioration in the official Peso to USD exchange rate would reduce the USD value of our net monetary assets and negatively impact pre-tax earnings by approximately $20 million. We will continue to assess the implications to our operations and financial reporting.

Recent Accounting Guidance	9 Months Ended
Recent Accounting Guidance	Sep. 30, 2021
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Guidance	RECENT ACCOUNTING GUIDANCE Recently Adopted Accounting Guidance In December 2019, the FASB issued Accounting Standards Update ("ASU") 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which was part of the FASB’s Simplification Initiative to identify, evaluate, and improve areas of GAAP for which cost and complexity can be reduced, while maintaining or improving the usefulness of the information provided to users of the financial statements. This ASU amends ASC 740, Income Taxes, by removing certain exceptions to the general principles, and clarifying and amending current guidance. The new standard is effective for fiscal years, and periods within those fiscal years, beginning after December 15, 2020. The company adopted this guidance on January 1, 2021 and it did not have a material impact on the company’s financial position, results of operation or cash flows.

The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 65
-Paragraph 1
-Subparagraph (g)(2)
-URI http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-URI http://asc.fasb.org/topic&trid=2122394

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 65
-Paragraph 1
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section S99
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=112272810&loc=SL108384541-122693

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 65
-Paragraph 1
-Subparagraph (i)(2)
-URI http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(iii)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(ii)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(i)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (g)(1)
-URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 65
-Paragraph 1
-Subparagraph (j)
-URI http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(iv)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 926
-SubTopic 20
-Section 65
-Paragraph 2
-Subparagraph (f)(1)
-URI http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section S99
-Paragraph 5
-Subparagraph (SAB Topic 11.M.Q2)
-URI http://asc.fasb.org/extlink&oid=112272810&loc=d3e31137-122693

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 926
-SubTopic 20
-Section 65
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 926
-SubTopic 20
-Section 65
-Paragraph 2
-Subparagraph (f)(3)
-URI http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 10
-Section 65
-Paragraph 4
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (h)(2)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 10
-Section 65
-Paragraph 4
-Subparagraph (e)(2)
-URI http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 65
-Paragraph 8
-Subparagraph (e)(1)

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 65
-Paragraph 8
-Subparagraph (e)(2)

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 65
-Paragraph 8
-Subparagraph (e)(3)

Revenue from Contract with Customer [Abstract]

Divestitures and Other Transactions	3 Months Ended
Divestitures and Other Transactions	Sep. 30, 2021
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]	DIVESTITURES AND OTHER TRANSACTIONS Separation Agreements In connection with the Distributions, DuPont, Corteva, and Dow (together, the “Parties” and each a “Party”) have entered into certain agreements to effect the Separation, provide for the allocation of DowDuPont’s assets, employees, liabilities and obligations (including its investments, property and employee benefits and tax-related assets and liabilities) among the Parties, and provide a framework for Corteva's relationship with Dow and DuPont following the Separations and Distributions (collectively, the "Separation Agreements"). For additional information see Note 13 - Commitments and Contingent Liabilities. DuPont Pursuant to the Separation Agreements, DuPont and Corteva indemnifies the other against certain litigation, environmental, tax, workers' compensation and other liabilities that arose prior to the Corteva Distribution. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. At September 30, 2021, the indemnification assets are $25 million within accounts and notes receivable - net and $70 million within other assets in the interim Consolidated Balance Sheet. At September 30, 2021, the indemnification liabilities are $76 million within other noncurrent obligations in the interim Consolidated Balance Sheet. Dow Pursuant to the Separation Agreements, Dow and Corteva indemnifies the other against certain litigation, environmental, tax and other liabilities that arose prior to the Corteva Distribution. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. At September 30, 2021, the indemnification liabilities are $54 million within accrued and other current liabilities and $14 million within other noncurrent obligations in the interim Consolidated Balance Sheet.

Revenue (Notes)

9 Months Ended

Sep. 30, 2021

Revenue from Contract with Customer

REVENUE

Revenue Recognition

Products

Substantially all of Corteva's revenue is derived from product sales. Product sales consist of sales of Corteva's products to farmers, distributors, and manufacturers. Corteva considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year. However, the company has some long-term contracts which can span multiple years.

Revenue from product sales is recognized when the customer obtains control of the company's product, which occurs at a point in time according to shipping terms. Payment terms are generally less than one year from invoicing. The company elected the practical expedient and does not adjust the promised amount of consideration for the effects of a significant financing component when the company expects it will be one year or less between when a customer obtains control of the company's product and when payment is due. The company has elected to recognize shipping and handling activities when control has transferred to the customer as an expense in cost of goods sold. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues. In addition, the company elected the practical expedient to expense any costs to obtain contracts as incurred, as the amortization period for these costs would have been one year or less.

The transaction price includes estimates of variable consideration, such as rights of return, rebates, and discounts, that are reductions in revenue. All estimates are based on the company's historical experience, anticipated performance, and the company's best judgment at the time the estimate is made. Estimates of variable consideration included in the transaction price utilize either the expected value method or most likely amount depending on the nature of the variable consideration. These estimates are reassessed each reporting period and are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur upon resolution of uncertainty associated with the variable consideration. The majority of contracts have a single performance obligation satisfied at a point in time and the transaction price is stated in the contract, usually as quantity times price per unit. For contracts with multiple performance obligations, the company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances.

Licenses of Intellectual Property

Corteva enters into licensing arrangements with customers under which it licenses its intellectual property. Revenue from the majority of intellectual property licenses is derived from sales-based royalties. Revenue for licensing agreements that contain sales-based royalties is recognized at the later of (i) when the subsequent sale occurs or (ii) when the performance obligation to which some or all of the royalty has been allocated is satisfied.

Remaining Performance Obligations

Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. The company applies the practical expedient to disclose the transaction price allocated to the remaining performance obligations for only those contracts with an original duration of one year or more. The transaction price allocated to remaining performance obligations with an original duration of more than one year related to material rights granted to customers for contract renewal options were $122 million, $115 million and $114 million at September 30, 2021, December 31, 2020 and September 30, 2020, respectively. The company expects revenue to be recognized for the remaining performance obligations over the next one year to six years.

Contract Balances

Contract liabilities primarily reflect deferred revenue from prepayments under contracts with customers where the company receives advance payments for products to be delivered in future periods. Corteva classifies deferred revenue as current or noncurrent based on the timing of when the company expects to recognize revenue. Contract assets primarily include amounts related to conditional rights to consideration for completed performance not yet invoiced. Accounts receivable are recorded when the right to consideration becomes unconditional.


Contract Balances	September 30, 2021		December 31, 2020		September 30, 2020
(In millions)	September 30, 2021		December 31, 2020		September 30, 2020
Accounts and notes receivable - trade1	$	4,744	$	3,917	$	4,638
Contract assets - current2	$	24	$	22	$	21
Contract assets - noncurrent3	$	60	$	54	$	52
Deferred revenue - current	$	692	$	2,662	$	402
Deferred revenue - noncurrent4	$	111	$	116	$	106

1.Included in accounts and notes receivable - net in the interim Consolidated Balance Sheets.

2.Included in other current assets in the interim Consolidated Balance Sheets.

3.Included in other assets in the interim Consolidated Balance Sheets.

4.Included in other noncurrent obligations in the interim Consolidated Balance Sheets.

Revenue recognized during the nine months ended September 30, 2021 and 2020 from amounts included in deferred revenue at the beginning of the period was $2,454 million and $2,195 million, respectively.

Disaggregation of Revenue

Corteva's operations are classified into two reportable segments: Seed and Crop Protection. The company disaggregates its revenue by major product line and geographic region, as the company believes it best depicts the nature, amount and timing of its revenue and cash flows. Net sales by major product line are included below:


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
Corn	$	437	$	303	$	4,505	$	4,224
Soybean	157		116		1,494		1,382
Other oilseeds	94		62		661		529
Other	50		42		350		381
Seed	738		523		7,010		6,516
Herbicides	782		583		2,737		2,315
Insecticides	416		395		1,261		1,218
Fungicides	339		261		911		714
Other	96		101		257		247
Crop Protection	1,633		1,340		5,166		4,494
Total	$	2,371	$	1,863	$	12,176	$	11,010

Sales are attributed to geographic regions based on customer location. Net sales by geographic region and segment are included below:


Seed	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
North America1	$	168	$	97	$	4,482	$	4,290
EMEA2	153		117		1,398		1,262
Latin America	334		246		842		668
Asia Pacific	83		63		288		296
Total	$	738	$	523	$	7,010	$	6,516


Crop Protection	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
North America1	$	422	$	390	$	1,693	$	1,528
EMEA2	237		198		1,304		1,163
Latin America	763		559		1,361		1,086
Asia Pacific	211		193		808		717
Total	$	1,633	$	1,340	$	5,166	$	4,494

1.Represents U.S. & Canada.

2.Europe, Middle East, and Africa ("EMEA").

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Restructuring and Related Activities [Abstract]

Restructuring and Asset Related Charges

9 Months Ended

Sep. 30, 2021

Restructuring and Related Activities Disclosure [Text Block]

RESTRUCTURING AND ASSET RELATED CHARGES - NET

2021 Restructuring Actions

As discussed in the 2020 Annual Report, on February 1, 2021, Corteva approved restructuring actions designed to right-size and optimize its footprint and organizational structure according to the business needs in each region with the focus on driving continued cost improvement and productivity. As a result of these actions, the company expects to record total pre-tax restructuring charges of approximately $150 million, comprised of approximately $65 million of severance and related benefit costs, $35 million of asset related charges, $10 million of asset retirement obligations and $40 million of costs related to contract terminations (contract terminations includes early lease terminations). The restructuring actions associated with this charge are expected to be substantially complete in 2021.

The charges related to the 2021 Restructuring Actions related to the segments, as well as corporate expenses, were as follows:


	Three Months Ended September 30,		Nine Months Ended September 30,
(In millions)	2021		2021
Seed	$	4	$	21
Crop Protection	4		41
Corporate expenses	9		65
Total	$	17	$	127

The following table is a summary of charges incurred related to 2021 Restructuring Actions for the three and nine months ended September 30, 2021:


	Three Months Ended September 30,		Nine Months Ended September 30,
(In millions)	2021		2021
Severance and related benefit costs	$	9	$	58
Asset related charges	7		29
Contract termination charges	1		40
Total restructuring and asset charges - net	$	17	$	127

A reconciliation of the December 31, 2020 to the September 30, 2021 liability balances related to the 2021 Restructuring Actions is summarized below:


(In millions)	Severance and Related Benefit Costs		Asset Related1		Contract Termination2		Total
Balance at December 31, 2020	$	—	$	—	$	—	$	—
Charges to income from continuing operations	58		29		40		127
Payments	(14)		—		(26)		(40)
Asset write-offs	—		(29)		—		(29)
Balance at September 30, 2021	$	44	$	—	$	14	$	58

1.In addition, the company has a liability recorded for asset retirement obligations of $6 million as of September 30, 2021.

2.The liability for contract terminations includes lease obligations. The cash impact of these obligations will be substantially complete by 2022.

Execute to Win Productivity Program

During the first quarter of 2020, Corteva approved restructuring actions designed to improve productivity through optimizing certain operational and organizational structures primarily related to the Execute to Win Productivity Program. Through the third quarter of 2021, the company recorded net pre-tax restructuring charges of $186 million inception-to-date under the Execute to Win Productivity Program, consisting of $123 million of asset related charges and $63 million of severance and related benefit costs. The company does not anticipate any additional material charges from the Execute to Win Productivity Program as actions associated with this charge were substantially complete by the end of 2020.

The Execute to Win Productivity Program charges related to the segments, as well as corporate expenses, were as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
Seed	$	—	$	—	$	—	$	3
Crop Protection	4		30		10		85
Corporate expenses	—		—		—		46
Total	$	4	$	30	$	10	$	134

The following table is a summary of charges incurred related to the Execute to Win Productivity Program for the three and nine months ended September 30, 2021 and 2020:


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
Severance and related benefit costs	$	—	$	—	$	—	$	46
Asset related charges	4		30		10		88
Total restructuring and asset related charges - net	$	4	$	30	$	10	$	134

A reconciliation of the December 31, 2020 to the September 30, 2021 liability balances related to the Execute to Win Productivity Program is summarized below:


(In millions)	Severance and Related Benefit Costs		Asset Related1		Total
Balance at December 31, 2020	$	53	$	3	$	56
Charges to income from continuing operations	—		10		10
Payments	(24)		(3)		(27)

Asset write-offs	—		(10)		(10)
Balance at September 30, 2021	$	29	$	—	$	29

1.In addition, the company has a liability recorded for asset retirement obligations of $18 million as of September 30, 2021.

Other Asset Related Charges

During the three and nine months ended September 30, 2021, the company recognized $5 million and $124 million, respectively, in restructuring and asset related charges - net in the interim Consolidated Statements of Operations, from non-cash accelerated prepaid royalty amortization expense related to Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits.

Supplementary Information

9 Months Ended

Sep. 30, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Additional Financial Information Disclosure [Text Block]

SUPPLEMENTARY INFORMATION


Other Income - Net	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
Interest income	$	19	$	11	$	58	$	38
Equity in (losses) / earnings of affiliates - net	(1)		—		4		(3)
Net gain (loss) on sales of businesses and other assets1	1		1		2		(29)
Net exchange gains / (losses)2	2		(67)		(47)		(127)
Non-operating pension and other post employment benefit credit3	326		93		979		275
Miscellaneous income (expense) - net4	31		(8)		17		(34)
Other income - net	$	378	$	30	$	1,013	$	120

1.The nine months ended September 30, 2020 includes a loss of $(53) million relating to the sale of the La Porte site, for which the company signed an agreement in 2020, and closed during the first quarter of 2021.

2.Includes net pre-tax exchange losses of $(16) million and $(53) million associated with the devaluation of the Argentine peso for the three and nine months ended September 30, 2021, respectively, and $(26) million and $(56) million for the three and nine months ended September 30, 2020, respectively.

3.Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement loss).

4.Miscellaneous expense - net for the three and nine months ended September 30, 2021 and 2020 includes losses on sale of receivables, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, and other items. Miscellaneous expense - net for the three and nine months ended September 30, 2021 also includes a gain from remeasurement of an equity investment and for the nine months ended September 30, 2021 includes realized losses on sale of available-for-sale securities.

The following table summarizes the impacts of the company's foreign currency hedging program on the company's results of operations. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the U.S., whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in other income - net and the related tax impact is recorded in provision for income taxes on continuing operations in the interim Consolidated Statements of Operations.


(In millions)	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Subsidiary Monetary Position Losses
Pre-tax exchange losses	$	(32)	$	(61)	$	(47)	$	(300)
Local tax benefits / (expenses)	3		16		(11)		44
Net after-tax impact from subsidiary exchange losses	$	(29)	$	(45)	$	(58)	$	(256)

Hedging Program Gains
Pre-tax exchange gains (losses)	$	34	$	(6)	$	—	$	173
Tax (expenses) / benefits	(8)		2		—		(41)
Net after-tax impact from hedging program exchange gains (losses)	$	26	$	(4)	$	—	$	132

Total Exchange Losses
Pre-tax exchange gains (losses)	$	2	$	(67)	$	(47)	$	(127)
Tax (expenses) benefits	(5)		18		(11)		3
Net after-tax exchange losses	$	(3)	$	(49)	$	(58)	$	(124)

Cash, cash equivalents and restricted cash equivalents

The following table provides a reconciliation of cash and cash equivalents and restricted cash equivalents presented in the interim Consolidated Balance Sheets to the total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows. Corteva classifies restricted cash equivalents as current or noncurrent based on the nature of the restrictions, which are included in other current assets and other assets, respectively, in the interim Consolidated Balance Sheets.


(In millions)	September 30, 2021		December 31, 2020		September 30, 2020
Cash and cash equivalents	$	2,779	$	3,526	$	2,768
Restricted cash equivalents	361		347		354
Total cash, cash equivalents and restricted cash equivalents	$	3,140	$	3,873	$	3,122

Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	INCOME TAXES For periods between the Merger Effectiveness Time and the Corteva Distribution, Corteva and its subsidiaries were included in DowDuPont's consolidated federal income tax group and consolidated tax return. Generally, the consolidated tax liability of the DowDuPont U.S. tax group for each year was apportioned among the members of the consolidated group based on each member’s separate taxable income. Corteva, DuPont and Dow intend that to the extent Federal and/or State corporate income tax liabilities are reduced through the utilization of tax attributes of the other, settlement of any receivable and payable generated from the use of the other party’s sub-group attributes will be in accordance with a tax matters agreement. See Note 3 - Divestitures and Other Transactions, for further information related to indemnifications between Corteva, DuPont and Dow. Each year the company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. Positions challenged by the tax authorities may be settled or appealed by the company. As a result, there is an uncertainty in income taxes recognized in the company's financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. The ultimate resolution of such uncertainties is not expected to have a material impact on the company's results of operations. During the three and nine months ended September 30, 2021, the company recognized $32 million and $58 million, respectively, of net tax benefits to provision for income taxes on continuing operations associated with changes in accruals for certain prior year tax positions in various jurisdictions, including a $22 million tax benefit associated with U.S. research and development tax credits. During the nine months ended September 30, 2020, the company recognized a tax benefit of $51 million to provision for income taxes on continuing operations related to a return to accrual adjustment associated with an elective change in accounting method for the 2019 tax year impact of the 2017 Tax Cuts and Jobs Act 's (“The Act”) foreign tax provisions. During the nine months ended September 30, 2020 the company recognized a tax benefit of $14 million to provision for income taxes on continuing operations related to a return to accrual adjustment to reflect a change in estimate on the impact of a tax law enactment in a foreign jurisdiction. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of the program, which resides in the U.S., is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions, which can drive material impacts on the company's effective tax rate. For further discussion of pre-tax and after-tax impacts of the company's foreign currency hedging program and net monetary asset programs, refer to Note 6 - Supplementary Information.

Earnings Per Share [Text Block]

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details

Earnings Per Share (Notes)

9 Months Ended

Sep. 30, 2021

Earnings Per Share [Abstract]

EARNINGS PER SHARE OF COMMON STOCK

The following tables provide earnings per share calculations for the periods indicated below:


Net Income (Loss) for Earnings Per Share Calculations - Basic and Diluted	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
Income (loss) from continuing operations after income taxes	$	36	$	(390)	$	1,667	$	657
Net income attributable to continuing operations noncontrolling interests	2		2		8		18

Income (loss) from continuing operations available to Corteva common stockholders	34		(392)		1,659		639
(Loss) income from discontinued operations available to Corteva common stockholders	(4)		—		(59)		1
Net income (loss) available to common stockholders	$	30	$	(392)	$	1,600	$	640


Earnings (Loss) Per Share Calculations - Basic	Three Months Ended September 30,				Nine Months Ended September 30,
(Dollars per share)	2021		2020		2021		2020
Earnings (loss) per share of common stock from continuing operations	$	0.05	$	(0.52)	$	2.25	$	0.85
Loss per share of common stock from discontinued operations	(0.01)		—		(0.08)		—
Earnings (loss) per share of common stock	$	0.04	$	(0.52)	$	2.17	$	0.85


Earnings (Loss) Per Share Calculations - Diluted	Three Months Ended September 30,				Nine Months Ended September 30,
(Dollars per share)	2021		2020		2021		2020
Earnings (loss) per share of common stock from continuing operations	$	0.05	$	(0.52)	$	2.23	$	0.85
Loss per share of common stock from discontinued operations	(0.01)		—		(0.08)		—
Earnings (loss) per share of common stock	$	0.04	$	(0.52)	$	2.15	$	0.85


Share Count Information	Three Months Ended September 30,		Nine Months Ended September 30,
(Shares in millions)	2021	2020	2021	2020
Weighted-average common shares - basic	733.8	749.5	738.1	749.5
Plus dilutive effect of equity compensation plans1	5.7	—	5.9	2.5

Weighted-average common shares - diluted	739.5	749.5	744.0	752.0
Potential shares of common stock excluded from EPS calculations2	3.0	14.6	3.1	9.7

1.Diluted earnings per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.

2.These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been anti-dilutive.

Accounts and Notes Receivable (Notes)

9 Months Ended

Sep. 30, 2021

Accounts and Notes Receivable [Abstract]

Loans, Notes, Trade and Other Receivables Disclosure [Text Block]

ACCOUNTS AND NOTES RECEIVABLE - NET


(In millions)	September 30, 2021		December 31, 2020		September 30, 2020
Accounts receivable – trade1	$	3,336	$	3,754	$	3,231
Notes receivable – trade1,2	1,408		163		1,407
Other3	1,074		1,009		989
Total accounts and notes receivable - net	$	5,818	$	4,926	$	5,627

1.Accounts receivable – trade and notes receivable - trade are net of allowances of $210 million at September 30, 2021, $208 million at December 31, 2020, and $210 million at September 30, 2020. Allowances are equal to the estimated uncollectible amounts and are based on the expected credit losses and were developed using a loss-rate method.

2.Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of September 30, 2021, December 31, 2020, and September 30, 2020 there were no significant impairments related to current loan agreements.

3.Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 10 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $84 million, $106 million, and $92 million as of September 30, 2021, December 31, 2020, and September 30, 2020, respectively.

Accounts and notes receivable are carried at the expected amount to be collected, which approximates fair value. The company establishes the allowance for doubtful receivables using a loss-rate method where the loss rate is developed using past events, historical experience, current conditions and forecasts that affect the collectability of the financial assets.

The following table summarizes changes in the allowance for doubtful receivables for the nine months ended September 30, 2021 and 2020:


(In millions)
2020
Balance at December 31, 2019	$	174
Net provision for credit losses1	54
Write-offs charged against allowance / other1	(18)
Balance at September 30, 2020	$	210

2021
Balance at December 31, 2020	$	208
Net provision for credit losses	(7)
Write-offs charged against allowance / other	9



Balance at September 30, 2021	$	210

1.Prior year classifications in the changes in the allowance for doubtful receivables have been revised. Revisions did not impact the amount of the provision or the allowance for doubtful receivables recorded in the interim Consolidated Statements of Operations or the interim Consolidated Balance Sheets.

The company enters into various factoring agreements with third-party financial institutions to sell its trade receivables under both recourse and non-recourse agreements in exchange for cash proceeds. These financing arrangements result in a transfer of the company's receivables and risks to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are derecognized from the interim Consolidated Balance Sheets upon transfer, and the company receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, which is typically provided through a guarantee of accounts in the event of customer default, the guarantee obligation is measured using market data from similar transactions and reported as a current liability in the interim Consolidated Balance Sheets.

Trade receivables sold under these agreements were $70 million and $257 million for the three and nine months ended September 30, 2021, respectively, and $44 million and $221 million for the three and nine months ended September 30, 2020, respectively. The trade receivables sold that remained outstanding under these agreements which include an element of recourse as of September 30, 2021, December 31, 2020, and September 30, 2020 were $173 million, $157 million, and $178 million, respectively. The net proceeds received are included in cash used for operating activities in the interim Consolidated Statements of Cash Flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of receivables in other income - net in the interim Consolidated Statements of Operations. The loss on sale of receivables was $11 million and $54 million for the three and nine months ended September 30, 2021, respectively, and

$11 million and $49 million for the three and nine months ended September 30, 2020, respectively. See Note 13 - Commitments and Contingent Liabilities for additional information on the company’s guarantees.

Inventories

9 Months Ended

Sep. 30, 2021

Inventory Disclosure [Abstract]

Inventory Disclosure [Text Block]

INVENTORIES


(In millions)	September 30, 2021		December 31, 2020		September 30, 2020
Finished products	$	1,871	$	2,584	$	2,074
Semi-finished products	2,028		1,813		1,878
Raw materials and supplies	518		485		422
Total inventories	$	4,417	$	4,882	$	4,374

Other Intangible Assets

9 Months Ended

Sep. 30, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets Disclosure [Text Block]

OTHER INTANGIBLE ASSETS

The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows:


(In millions)	September 30, 2021						December 31, 2020						September 30, 2020
	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
Intangible assets subject to amortization (Definite-lived):
Germplasm	$	6,265	$	(507)	$	5,758	$	6,265	$	(317)	$	5,948	$	6,265	$	(253)	$	6,012
Customer-related	1,956		(460)		1,496		1,984		(380)		1,604		1,966		(352)		1,614
Developed technology	1,485		(641)		844		1,451		(525)		926		1,463		(499)		964
Trademarks/trade names1	2,012		(152)		1,860		2,019		(99)		1,920		161		(86)		75
Favorable supply contracts	475		(373)		102		475		(302)		173		475		(279)		196
Other2	407		(252)		155		405		(239)		166		405		(233)		172
Total other intangible assets with finite lives	12,600		(2,385)		10,215		12,599		(1,862)		10,737		10,735		(1,702)		9,033

Intangible assets not subject to amortization (Indefinite-lived):
IPR&D	10		—		10		10		—		10		10		—		10
Trade name1													1,871		—		1,871

Total other intangible assets	10		—		10		10		—		10		1,881		—		1,881
Total	$	12,610	$	(2,385)	$	10,225	$	12,609	$	(1,862)	$	10,747	$	12,616	$	(1,702)	$	10,914

1.Beginning on October 1, 2020, the company changed its indefinite life assertion of its trade name asset to definite lived with a useful life of 25 years. This change is the result of the launch of BrevantTM seed in the retail channel in the U.S. Prior to changing the useful life of the trade name asset, the company tested the asset for impairment under ASC 350- Intangibles, Goodwill and Other, concluding the asset was not impaired.

2.Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $180 million and $543 million for the three and nine months ended September 30, 2021, respectively, and $162 million and $501 million for the three and nine months ended September 30, 2020, respectively. The current estimated aggregate pre-tax amortization expense from continuing operations for the remainder of 2021 and each of the next five years is approximately $178 million, $700 million, $620 million, $606 million, $569 million and $558 million, respectively.

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities

9 Months Ended

Sep. 30, 2021

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES

The following tables summarize Corteva's short-term borrowings and finance lease obligations:


Short-term borrowings and finance lease obligations
(In millions)	September 30, 2021		December 31, 2020		September 30, 2020
Commercial paper	$	802	$	—	$	926
Repurchase facility	550		—		1,175
Other loans - various currencies	18		1		39
Long-term debt payable within one year	1		1		1
Finance lease obligations payable within one year	1		1		1
Total short-term borrowings and finance lease obligations	$	1,372	$	3	$	2,142

The estimated fair value of the company's short-term borrowings, including interest rate financial instruments, was determined using Level 2 inputs within the fair value hierarchy. Based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities, the fair value of the company's short-term borrowings and finance lease obligations was approximately carrying value.

The fair value of the company’s long-term borrowings, including debt due within one year, was $1,134 million, $1,168 million, and $1,164 million as of September 30, 2021, December 31, 2020, and September 30, 2020, respectively, and was determined using quoted market prices for the same or similar issues, or current rates offered to the company for debt of the same remaining maturities (Level 2 inputs).

Debt Offering

In May 2020, EID issued $500 million of 1.70 percent Senior Notes due 2025 and $500 million of 2.30 percent Senior Notes due 2030 (the May 2020 Debt Offering). The proceeds of this offering are intended to be used for general corporate purposes.

Repurchase Facility

In February 2021, the company entered into a new committed receivable repurchase facility of up to $1 billion (the "2021 Repurchase Facility") which expires in December 2021. Under the 2021 Repurchase Facility, Corteva may sell a portfolio of available and eligible outstanding customer notes receivables to participating institutions and simultaneously agree to repurchase at a future date. The 2021 Repurchase Facility is considered a secured borrowing with the customer notes receivables inclusive of those that are sold and repurchased, equal to 105 percent of the outstanding amounts borrowed utilized as collateral. Borrowings under the 2021 Repurchase Facility have an interest rate of LIBOR+0.85 percent.

As of September 30, 2021, $578 million of notes receivable, recorded in accounts and notes receivable - net in the interim Consolidated Balance Sheets, were pledged as collateral against outstanding borrowings under the 2021 Repurchase Facility of $550 million, recorded in short-term borrowings and finance lease obligations in the interim Consolidated Balance Sheet.

Revolving Credit Facilities

In November 2018, EID entered into a $3 billion 5-year revolving credit facility and a $3 billion 3-year revolving credit facility (the “Revolving Credit Facilities”). The Revolving Credit Facilities became effective in May 2019. Corteva, Inc. became a party at the time of the Corteva Distribution. In May 2021, the company entered into an amendment that extended the maturity date of the 3-year revolving credit facility from May 2022 to May 2023. Other than the change in maturity date, there were no material modifications to the terms of the credit facility. The Revolving Credit Facilities may serve as a substitute to the company's commercial paper program, and can be used, from time to time, for general corporate purposes including, but not limited to, the funding of seasonal working capital needs. The Revolving Credit Facilities contain customary representations and warranties, affirmative and negative covenants and events of default that are typical for companies with similar credit ratings. Additionally, the Revolving Credit Facilities contain a financial covenant requiring that the ratio of total indebtedness to total capitalization for Corteva and its consolidated subsidiaries not exceed 0.60.

In March 2020, the company drew down $500 million under the $3 billion 3-year revolving credit facility as a result of the volatility and increased borrowing costs of commercial paper resulting from the unstable market conditions caused by the COVID-19 pandemic and repaid that borrowing in full in June 2020. There were no additional borrowings and the unused commitments under the 3-year revolving credit facility were $3 billion as of September 30, 2021.

Commitments and Contingent Liabilities

9 Months Ended

Sep. 30, 2021

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

COMMITMENTS AND CONTINGENT LIABILITIES

Guarantees

Indemnifications

In connection with acquisitions and divestitures, the company has indemnified respective parties against certain liabilities that may arise in connection with these transactions and business activities prior to the completion of the transactions. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. In addition, the company indemnifies its duly elected or appointed directors and officers to the fullest extent permitted by Delaware law, against liabilities incurred as a result of their activities for the company, such as adverse judgments relating to litigation matters. If the indemnified party were to incur a liability or have a liability increase as a result of a successful claim, pursuant to the terms of the indemnification, the company would be required to reimburse the indemnified party. The maximum amount of potential future payments is generally unlimited. See pages 24 and 25 for additional information relating to the indemnification obligations under the Chemours Separation Agreement and the Corteva Separation Agreement.

Obligations for Customers and Other Third Parties

The company has directly guaranteed various debt obligations under agreements with third parties related to customers and other third parties. At September 30, 2021, December 31, 2020 and September 30, 2020, the company had directly guaranteed $107 million, $94 million, and $96 million, respectively, of such obligations. These amounts represent the maximum potential amount of future (undiscounted) payments that the company could be required to make under the guarantees in the event of default by the guaranteed party. All of the maximum future payments at September 30, 2021 had terms less than one year. The maximum future payments include $22 million, $17 million and $20 million at September 30, 2021, December 31, 2020 and September 30, 2020, respectively, of guarantees related to the various factoring agreements that the company enters into with third-party financial institutions to sell its trade receivables. See Note 9 - Accounts and Notes Receivable - Net, for additional information.

The maximum future payments also include agreements with lenders to establish programs that provide financing for select customers. The terms of the guarantees are equivalent to the terms of the customer loans that are primarily made to finance customer invoices. The total amounts owed from customers to the lenders relating to these agreements was $615 million, $16 million and $637 million at September 30, 2021, December 31, 2020 and September 30, 2020, respectively.

The company assesses the payment/performance risk by assigning default rates based on the duration of the guarantees. These default rates are assigned based on the external credit rating of the counterparty or through internal credit analysis and historical default history for counterparties that do not have published credit ratings. For counterparties without an external rating or available credit history, a cumulative average default rate is used.

Indemnifications under Separation Agreements

The company has entered into various agreements where the company is indemnified for certain liabilities. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. See Note 3 - Divestitures and Other Transactions, to the interim Consolidated Financial Statements for additional information related to indemnifications between Corteva, DuPont and Dow.

Chemours/Performance Chemicals

Pursuant to the Chemours Separation Agreement resulting from the 2015 spin-off of the Performance Chemicals segment from Historical DuPont, Chemours indemnifies the company against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the distribution. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable.

In 2017, the Chemours Separation Agreement was amended to provide for a limited sharing of potential future liabilities related to alleged historical releases of perfluorooctanoic acids and its ammonium salts (“PFOA”) for a five-year period that began on July 6, 2017. In addition, in 2017, Chemours and EID settled multi-district litigation in the U.S. District Court for the Southern District of Ohio (“Ohio MDL”), resolving claims of about 3,550 plaintiffs alleging injury from exposure to PFOA in drinking water as a result of the historical manufacture or use of PFOA at the Washington Works plant outside Parkersburg, West Virginia. This plant was previously owned and/or operated by the performance chemicals segment of EID and is now owned and/or operated by Chemours.

On May 13, 2019, Chemours filed suit in the Delaware Court of Chancery against DuPont, EID, and Corteva, seeking, among other things, to limit its responsibility for the litigation and environmental liabilities allocated to and assumed by Chemours under the Chemours Separation Agreement (the “Delaware Litigation”). On March 30, 2020, the Court of Chancery granted a

motion to dismiss. On December 15, 2020, the Delaware Supreme Court affirmed the judgment of the Court of Chancery. Meanwhile, a confidential arbitration process regarding the same and other claims had proceeded (the “Pending Arbitration”).

On January 22, 2021, Chemours, DuPont, Corteva and EID entered into a binding memorandum of understanding containing a settlement to resolve legal disputes originating from the Delaware Litigation and Pending Arbitration, and to establish a cost sharing arrangement and escrow account to be used to support and manage potential future legacy per- and polyfluoroalkyl substances ("PFAS") liabilities arising out of pre-July 1, 2015 conduct (the “MOU”). The MOU replaces the 2017 amendment to the Chemours Separation Agreement. According to the terms of the cost sharing arrangement within the MOU, Corteva and DuPont together, on one hand, and Chemours, on the other hand, agreed to a 50-50 split of certain qualified expenses related to PFAS liabilities incurred over a term not to exceed twenty years or $4 billion of qualified spend and escrow account contributions (see below for discussion of escrow account) in the aggregate. DuPont’s and Corteva’s 50% share under the MOU will be limited to $2 billion, including qualified expenses and escrow contributions. These expenses and escrow account contributions will be subject to the existing Letter Agreement, under which DuPont and Corteva will each bear 50% of the first $300 million (up to $150 million each), and thereafter DuPont bears 71% and Corteva bears the remaining 29%.

In order to support and manage any potential future PFAS liabilities, the parties have also agreed to establish an escrow account ("MOU Escrow Account"). The MOU provides that (1) no later than each of September 30, 2021 and September 30, 2022, Chemours shall deposit $100 million into an escrow account and DuPont and Corteva shall together deposit $100 million in the aggregate into an escrow account and (2) no later than September 30 of each subsequent year through and including 2028, Chemours shall deposit $50 million into an escrow account and DuPont and Corteva shall together deposit $50 million in the aggregate into an escrow account. Subject to the terms and conditions set forth in the MOU, each party may be permitted to defer funding in any year (excluding 2021). Over this period, Chemours will deposit a total of $500 million in the account and DuPont and Corteva will deposit an additional $500 million pursuant to the terms of the Letter Agreement. Additionally, if on December 31, 2028, the balance of the escrow account (including interest) is less than $700 million, Chemours will make 50% of the deposits and DuPont and Corteva together will make 50% of the deposits necessary to restore the balance of the escrow account to $700 million. Such payments will be made in a series of consecutive annual equal installments commencing on September 30, 2029 pursuant to the escrow account replenishment terms as set forth in the MOU. The MOU provides that no withdrawals from the MOU Escrow Account can be made before year six, except to fund mutually agreed upon third-party settlements in excess of $125 million. Starting with year six, withdrawals can only be made to fund qualified spend if the parties’ aggregate qualified spend in that particular year is greater than $200 million. Beginning with year 11, the amounts in the MOU Escrow Account can be used to fund any qualified spend. Restricted cash classified as noncurrent at September 30, 2021 is related to the MOU Escrow Account.

During the three months ended September 30, 2021, the company contributed its initial deposit into the MOU Escrow Account, which is classified as noncurrent restricted cash equivalents and is included in other assets in the interim Consolidated Balance Sheets.

After the term of this arrangement, Chemours’ indemnification obligations under the original 2015 Chemours Separation Agreement, would continue unchanged, subject in each case to certain exceptions set out in the MOU. Under the MOU, Chemours waived specified claims regarding the construct of its 2015 spin-off transaction, and the parties will dismiss the Pending Arbitration regarding those claims. Additionally, the parties have agreed to resolve the Ohio MDL PFOA personal injury litigation (as discussed below). The parties are expected to cooperate in good faith to enter into additional agreements reflecting the terms set forth in the MOU.

During the three and nine months ended September 30, 2021, the company recorded charges of $8 million and $45 million, respectively, to (loss) income from discontinued operations after income taxes in the interim Consolidated Statement of Operations, related to the MOU. The charges in the nine months ended September 30, 2021 primarily relate to an increase in the environmental remediation accrual for Chemours' Fayetteville Works facility for estimated costs for on-site surface water and groundwater remediation to address and abate PFAS discharges arising out of pre-July 1, 2015 conduct. The increase is the result of further detailed engineering and design work related to Chemours’ environmental remediation activities at the site under the Consent Order between Chemours and the North Carolina Department of Environmental Quality.

Corteva Separation Agreement

On April 1, 2019, in connection with the Dow Distribution, Corteva, DuPont and Dow entered into the Corteva Separation Agreement, the Tax Matters Agreement, the Employee Matters Agreement, and certain other agreements (collectively, the “Corteva Separation Agreements”). The Corteva Separation Agreements allocate among Corteva, DuPont and Dow certain liabilities and obligations among the parties and provides for indemnification obligation among the parties. Under the Corteva Separation Agreements, DuPont will indemnify Corteva against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the Corteva Distribution and Dow indemnifies Corteva against certain litigation and other liabilities that relate to the Historical Dow business, but were transferred over as part of the common control combination with

DAS, and Corteva indemnifies DuPont and Dow for certain liabilities. The term of this indemnification is generally indefinite with exceptions, and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. See Note 3 - Divestitures and Other Transactions, to the interim Consolidated Financial Statements for additional information relating to the Separation.

Under the Corteva Separation Agreement, certain legacy EID liabilities from discontinued and/or divested operations and businesses of EID (including Performance Chemicals) (a “stray liability”) were allocated to Corteva or DuPont. For those stray liabilities allocated to Corteva (which may include a specified amount of liability associated with that liability), Corteva is responsible for liabilities in an amount up to that specified amount plus an additional $200 million and, for those stray liabilities allocated to DuPont (which may include a specified amount of liability associated with that liability), DuPont is responsible for liabilities up to a specified amount plus an additional $200 million. Once each company has met the $200 million threshold, Corteva and DuPont will share future liabilities proportionally on the basis of 29% and 71%, respectively; provided, however, that for PFAS, DuPont will manage such liabilities with Corteva and DuPont sharing the costs on a 50% - 50% basis starting from $1 and up to $300 million (with such amount, up to $150 million, to be credited to each company’s $200 million threshold) and once the $300 million threshold is met, then the companies will share proportionally on the basis of 29% and 71% respectively, subject to a $1 million de minimis requirement. During the second quarter of 2021, the aggregate amount of the Company’s cash spent and liabilities accrued exceeded the stray liability thresholds, including PFAS, noted above. Therefore, liabilities recognized subsequent to the second quarter of 2021 will be shared at the reduced rates noted above.

Litigation

The company is subject to various legal proceedings, including, but not limited to, product liability, intellectual property, antitrust, commercial, property damage, personal injury, environmental and regulatory matters arising out of the normal course of its current businesses or legacy EID businesses unrelated to Corteva’s current businesses but allocated to Corteva as part of the separation of Corteva from DowDuPont. It is not possible to predict the outcome of these various proceedings, as considerable uncertainty exists. The company records accruals for legal matters when the information available indicates that it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Accruals may reflect the impact and status of negotiations, settlements, rulings, advice from counsel and other information and events that may pertain to a particular matter. For the litigation matters discussed below, management believes that it is reasonably possible that the company could incur liabilities in excess of amounts accrued, the ultimate liability for which could be material to the results of operations and the cash flows in the period recognized. However, the company is unable to estimate the possible loss beyond amounts accrued due to various reasons, including, among others, that the underlying matters are either in early stages and/or have significant factual issues to be resolved. In addition, even when the company believes it has substantial defenses, the company may consider settlement of matters if it believes it is in the best interest of the company.

Chlorpyrifos Lawsuits

As of September 30, 2021, there were pending personal injury lawsuits filed and additional asserted claims against the former Dow Agrosciences LLC, alleging injuries related to chlorpyrifos exposure, the active ingredient in Lorsban®, an insecticide used by commercial farms for field fruit, nut and vegetable crops. Corteva ended its production of Lorsban® in 2020. Chlorpyrifos products are restricted-use pesticides, which are not available for purchase or use by the general public, and may only be sold to, and used by, certified applicators or someone under the certified applicator's direct supervision. These lawsuits do not relate to Dursban®, a residential type chlorpyrifos product that was authorized for indoor purposes, which was discontinued over two decades ago prior to the Merger and Corteva’s formation and Separation. Claimants allege personal injury, including autism, developmental delays and/or decreased neurologic function, resulting from farm worker exposure and bystander drift and in utero exposure to chlorpyrifos. Certain claimants have also put forth remediation claims due to alleged property contamination from chlorpyrifos. Discovery for the cases only recently begun and is expected to continue through the first quarter of 2022. Notwithstanding the company’s confidence in the safety of its former chlorpyrifos products, in certain circumstances the company may settle when determined to be in the best interest of the company.

Litigation related to legacy EID businesses unrelated to Corteva’s current businesses

PFAS, PFOA, PFOS and Other Related Liabilities

For purposes of this report, the term PFOA means collectively perfluorooctanoic acid and its salts, including the ammonium salt and does not distinguish between the two forms, and PFAS, which means per- and polyfluoroalkyl substances, including PFOA, PFOS (perfluorooctanesulfonic acid), GenX and other perfluorinated chemicals and compounds ("PFCs").

EID is a party to various legal proceedings relating to the use of PFOA by its former Performance Chemicals segment for which potential liabilities would be subject to the cost sharing arrangement under the MOU as long as it remains effective.

Leach Settlement and Ohio MDL Settlement

EID has residual liabilities under its 2004 settlement of a West Virginia state court class action, Leach v. EID, which alleged that PFOA from EID’s former Washington Works facility had contaminated area drinking water supplies and affected the health of area residents. The settlement class has about 80,000 members. In addition to relief that was provided to class

members years ago, the settlement requires EID to continue providing PFOA water treatment to six area water districts and private well users and to fund, through an escrow account, up to $235 million for a medical monitoring program for eligible class members. As of September 30, 2021, approximately $2 million had been disbursed from the account since its establishment in 2012 and the remaining balance is approximately $1 million.

The Leach settlement permits class members to pursue personal injury claims for six health conditions (and no others) that an expert panel appointed under the settlement reported in 2012 had a “probable link” (as defined in the settlement) with PFOA: pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol. After the panel reported its findings, approximately 3,550 personal injury lawsuits were filed in federal and state courts in Ohio and West Virginia and consolidated in multi-district litigation in the U.S. District Court for the Southern District of Ohio (“Ohio MDL”). The Ohio MDL was settled in early 2017 for $670.7 million in cash, with Chemours and EID (without indemnification from Chemours) each paying half.

Post-MDL Settlement PFOA Personal Injury Claims

The 2017 Ohio MDL settlement did not resolve claims of plaintiffs who did not have claims in the Ohio MDL or whose claims are based on diseases first diagnosed after February 11, 2017. The first trial for these claims, a kidney cancer case, resulted in a hung jury, while the second, Travis and Julie Abbot v. E.I du Pont de Nemours and Company (the “Abbot Case”), a testicular cancer case, resulted in a jury verdict of $40 million in compensatory damages and $10 million for loss of consortium. Following entry of the judgment by the court, EID filed post-trial motions to reduce the verdict, and to appeal the verdict on the basis of procedural and substantive legal errors made by the trial court. The trial court recently granted EID’s motion to reduce the loss of consortium award to conform with state tort reform laws limiting these damages to $250,000. The company is continuing its other appeals to reduce the jury verdict or eliminate its liability, in whole or part.

In January 2021, Chemours, DuPont and Corteva agreed to settle the remaining approximately 95 matters, as well as unfiled matters, remaining in the Ohio MDL, with the exception of the Abbot case, for $83 million, with Chemours contributing $29 million to the settlement, and DuPont and Corteva contributing $27 million each. The company recorded a liability for its share of the settlement, with a charge to (loss) income from discontinued operations after income taxes in the interim Consolidated Statement of Operations, during the year ended December 31, 2020, and paid $27 million during the nine months ended September 30, 2021. As agreed to in the settlement, the plaintiffs' counsel filed a motion to dissolve the MDL.

Other PFOA Matters

EID is a party to other PFOA lawsuits that do not involve claims for personal injury. Defense costs and any future liabilities that may arise out of these lawsuits are subject to the MOU and the cost sharing arrangement disclosed above. Under the MOU, fraudulent conveyance claims associated with these matters are not qualified expenses, unless Corteva, Inc. and EID would prevail on the merits of these claims.

New York. EID is a defendant in about 50 lawsuits, including a putative class action, brought by persons who live in and around Hoosick Falls, New York. These lawsuits assert claims for medical monitoring and property damage based on alleged PFOA releases from manufacturing facilities owned and operated by co-defendants in Hoosick Falls and allege that EID and 3M supplied some of the materials used at these facilities. EID is also one of more than ten defendants in a lawsuit brought by the Town of East Hampton, New York alleging PFOA and PFOS contamination of the town’s well water. Additionally, EID, along with 3M, Chemours and Dyneon, have been named defendants in complaints filed by eight water districts in Nassau County, New York alleging that the drinking water they provide to customers is contaminated with PFAS and seeking reimbursement for clean-up costs. The water district complaints also include allegations of fraudulent transfer.

New Jersey. At September 30, 2021, two lawsuits were pending, one brought by a local water utility and the second a putative class action, against EID alleging that PFOA from EID’s former Chambers Works facility contaminated drinking water sources. The putative class action was voluntarily dismissed without prejudice by the plaintiff.

In late March of 2019, the New Jersey State Attorney General filed four lawsuits against EID, Chemours, 3M and others alleging that operations at and discharges from former EID sites in New Jersey (Chambers Works, Pompton Lakes, Parlin and Repauno) damaged the State’s natural resources. Two of these lawsuits (those involving the Chambers Works and Parlin sites) allege contamination from PFAS. The Ridgewood Water District in New Jersey filed suit in the first quarter 2019 against EID, 3M, Chemours, and Dyneon alleging losses related to the investigation,

remediation and monitoring of polyfluorinated surfactants, including PFOA, in water supplies. DuPont and Corteva were subsequently added as defendants to these lawsuits.

Alabama / Others. EID is one of more than thirty defendants in a lawsuit by the Alabama water utility alleging contamination from PFCs, including PFOA, used by co-defendant carpet manufacturers to make their products more stain and grease resistant. In addition, the states of Alaska, Michigan, Mississippi, New Hampshire, South Dakota, and Vermont recently filed lawsuits against EID, Chemours, 3M and others, claiming, among other things, PFC (including PFOA) contamination of groundwater and drinking water. The complaints seek reimbursement for past and future costs to investigate and remediate the alleged contamination and compensation for the loss of value and use of the state’s natural resources. Motions to dismiss the Michigan, Vermont and New Hampshire cases have been denied.

Ohio. EID is a defendant in three lawsuits: an action by the State of Ohio based on alleged damage to natural resources, a putative nationwide class action brought on behalf of anyone who has detectable levels of PFAS in their blood serum, and an action by the City of Dayton claiming losses related to the investigation, remediation and monitoring of PFAS in water supplies.

Netherlands. In April 2021, four municipalities in the Netherlands filed complaints alleging contamination of land and groundwater resulting from the emission of PFOA and GenX by Corteva, DuPont and Chemours. The municipalities seek to recover costs incurred due to the alleged emissions, including damages for investigation costs, construction project delays, depreciation of land, soil remediation, liabilities to contractors, and attorneys’ fees.

Delaware. On July 13, 2021, Chemours, DuPont, EID and Corteva entered into a settlement agreement with the State of Delaware reflecting the companies’ and the State’s agreement to settle and fully resolve claims alleged against the companies regarding their historical Delaware operations, manufacturing, use and disposal of all chemical compounds, including PFAS. Under the settlement, the companies will collectively pay $50 million to fund environmental projects, including sampling and community environmental justice and equity grants, which shall be utilized to fund the Natural Resources and Sustainability Trust (the “NRST Trust”). If the companies, individually or jointly, within 8 years of the settlement, enter into a proportionally similar agreement to settle or resolve claims of another state for PFAS-related natural resource damages, for an amount greater than $50 million, the companies shall make a supplemental payment directly to the NRST Trust (“Supplemental Payment”) in an amount equal to such other states’ recovery in excess of $50 million. Supplemental Payment(s), if any, will not exceed $25 million in the aggregate. All amounts paid by the companies under the settlement are subject to the MOU and the Corteva Separation Agreement with Chemours bearing responsibility for 50%, or $25 million, of the $50 million payment due to the NRST and DuPont and Corteva each bearing $12.5 million of the remaining amount. As of September 30, 2021, an accrual has been established in relation to this settlement and during the nine months ended September 30, 2021, the company recorded a charge of $11 million to (loss) income from discontinued operations after income taxes in the interim Consolidated Statement of Operations. Under the settlement, if the state sues other parties and those parties seek contribution from the companies, the companies will have protection from contribution up to the amounts previously paid under the settlement agreement. The companies will also receive a credit up to the amount of the payment if the state seeks natural resource damage claims against the companies outside the scope of the settlement’s release of claims.

Aqueous Firefighting Foams. Approximately 1,760 cases have been filed against 3M and other defendants, including EID and Chemours, and more recently also including Corteva and DuPont, alleging PFOS or PFOA contamination of soil and groundwater from the use of aqueous firefighting foams. Most of those cases claim some form of property damage and seek to recover the costs of responding to this contamination and damages for the loss of use and enjoyment of property and diminution in value. Most of these cases have been transferred to a multidistrict litigation proceeding in federal district court in South Carolina. Approximately 1,600 of these cases were filed on behalf of firefighters who allege personal injuries (primarily kidney and testicular cancer) as a result of aqueous firefighting foams, while 96 are from municipal water districts. Most of these recent cases assert claims that the EID and Chemours separation constituted a fraudulent conveyance. A schedule of initial trials is expected to be established in the second half of 2021.

EID did not make firefighting foams, PFOS, or PFOS products. While EID made surfactants and intermediaries that some manufacturers used in making foams, which may have contained PFOA as an unintended byproduct or an impurity, EID’s products were not formulated with PFOA, nor was PFOA an ingredient of these products. EID has never made or sold PFOA as a commercial product.

Fayetteville Works Facility, North Carolina

Prior to the separation of Chemours, EID introduced GenX as a polymerization processing aid and a replacement for PFOA at the Fayetteville Works facility in Bladen County, North Carolina. The facility is now owned and operated by Chemours, which continues to manufacture and use GenX.

At September 30, 2021, several actions are pending in federal court against Chemours and EID relating to PFC discharges from the Fayetteville Works facility. One of these is a consolidated putative class action that asserts claims for medical monitoring and property damage on behalf of putative classes of property owners and residents in areas near or who draw drinking water from the Cape Fear River. Another action is a consolidated action brought by various North Carolina water authorities, including the Cape Fear Public Utility Authority and Brunswick County, that seek actual and punitive damages as well as injunctive relief. In another action with approximately 100 property owners near the Fayetteville Works facility, a complaint was filed against Chemours and EID in May 2020. The plaintiffs seek compensatory and punitive damages for their claims of private nuisance, trespass, and negligence allegedly caused by release of PFAS.

In addition to the federal court actions, there is an action on behalf of about 100 plaintiffs who own wells and property near the Fayetteville Works facility. The plaintiffs seek damages for nuisance allegedly caused by releases of certain PFCs from the site.

Generally, site-related expenses related GenX claims are subject to the cost sharing arrangements as defined in the MOU.

Environmental

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current law and existing technologies. These obligations are included in accrued and other current liabilities and other noncurrent obligations in the interim Consolidated Balance Sheet. It is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration.

For a discussion of the allocation of environmental liabilities under the Chemours Separation Agreement and the Corteva Separation Agreement, see the previous discussion on page 24.


	As of September 30, 2021
(In millions)	Indemnification Asset		Accrual balance3		Potential exposure above amount accrued3
Environmental Remediation Stray Liabilities
Chemours related obligations - subject to indemnity1,2	$	156	$	156	$	266
Other discontinued or divested businesses obligations1	10		77		187

Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont2	38		38		64

Environmental remediation liabilities not subject to indemnity	—		72		49

Indemnification liabilities related to the MOU4	9		111		20
Total	$	213	$	454	$	586

1.Represents liabilities that are subject to the $200 million thresholds and sharing arrangements as discussed on page 24, under the header "Corteva Separation Agreement."

2.The company has recorded an indemnification asset related to these accruals, including $40 million related to the Superfund sites.

3.Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates. Accrual balances includes $67 million for remediation of Superfund sites.

4.Represents liabilities that are subject to the $150 million thresholds and sharing agreements as discussed on page 23, under the header "Chemours / Performance Chemicals."

Stockholders' Equity

9 Months Ended

Sep. 30, 2021

Equity [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

STOCKHOLDERS' EQUITY

Share Buyback Plan

On August 5, 2021, Corteva, Inc. announced that its Board of Directors authorized a $1.5 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2021 Share Buyback Plan"). The timing, price and volume of purchases will be based on market conditions, relevant securities laws and other factors. In connection with the 2021 Share Buyback Plan, the company purchased and retired 1,167,000 shares during the three months ended September 30, 2021 in the open market for a total cost of $50 million.

On June 26, 2019, Corteva, Inc. announced that its Board of Directors authorized a $1 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2019 Share Buyback Plan").

In connection with the 2019 Share Buyback Plan, the company purchased and retired 3,408,000 shares and 15,378,000 shares, respectively, in the open market for a total cost of $150 million and $700 million during the three and nine months ended September 30, 2021, respectively. During the three and nine months ended September 30, 2020, the company purchased and retired 1,160,000 shares and 3,025,000 shares, respectively, in the open market for a total cost of $33 million and $83 million, respectively. Purchases under the 2019 Share Buyback Plan are now complete with the third quarter 2021 activity noted above.

Shares repurchased pursuant to Corteva's share buyback plans are immediately retired upon purchase. Repurchased common stock is reflected as a reduction of stockholders' equity. The company's accounting policy related to its share repurchases is to reduce its common stock based on the par value of the shares and to reduce its retained earnings for the excess of the repurchase price over the par value. When Corteva has an accumulated deficit balance, the excess over the par value is applied to APIC. When Corteva has retained earnings, the excess is charged entirely to retained earnings.

Noncontrolling Interest

In June 2020, the company completed the acquisition of the remaining 46.5 percent interest in the Phytogen Seed Company, LLC joint venture from J. G. Boswell Company. As the purchase of the remaining interest did not result in a change of control, the difference between the carrying value of the noncontrolling interest and the consideration paid, net of taxes was recorded within equity.

Corteva, Inc. owns 100 percent of the outstanding common shares of EID. However, EID has preferred stock outstanding to third parties which is accounted for as a non-controlling interest in Corteva's interim Consolidated Balance Sheets. Each share of EID Preferred Stock - $4.50 Series and EID Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EID and was unaffected by the Corteva Distribution.

Below is a summary of the EID Preferred Stock at September 30, 2021, December 31, 2020, and September 30, 2020, which is classified as noncontrolling interests in Corteva's interim Consolidated Balance Sheets.


Shares in thousands			Number of Shares
Authorized			23,000
$4.50 Series, callable at $120			1,673
$3.50 Series, callable at $102			700

Other Comprehensive (Loss) Income

The changes and after-tax balances of components comprising accumulated other comprehensive loss are summarized below:


(In millions)	Cumulative Translation Adjustment1		Derivative Instruments		Pension Benefit Plans		Other Benefit Plans		Unrealized Gain (Loss) on Investments		Total






2020
Balance January 1, 2020	$	(1,944)	$	2	$	(1,247)	$	(81)	$	—	$	(3,270)
Other comprehensive (loss) income before reclassifications	(507)		(23)		(10)		2		—		(538)
Amounts reclassified from accumulated other comprehensive loss	—		7		4		1		—		12
Net other comprehensive (loss) income	(507)		(16)		(6)		3		—		(526)
Balance September 30, 2020	$	(2,451)	$	(14)	$	(1,253)	$	(78)	$	—	$	(3,796)

2021
Balance January 1, 2021	$	(1,970)	$	(67)	$	(1,433)	$	590	$	(10)	$	(2,890)
Other comprehensive (loss) income before reclassifications	(424)		115		(6)		1		3		(311)
Amounts reclassified from accumulated other comprehensive loss	—		(8)		32		(475)		7		(444)
Net other comprehensive (loss) income	(424)		107		26		(474)		10		(755)

Balance September 30, 2021	$	(2,394)	$	40	$	(1,407)	$	116	$	—	$	(3,645)

1.The cumulative translation adjustment loss for the nine months ended September 30, 2021 was primarily driven by strengthening of the USD against the European Euro ("EUR"), Swiss Franc ("CHF") and Brazilian Real ("BRL"). The cumulative translation adjustment loss for the nine months ended September 30, 2020 was primarily driven by strengthening of the USD against the Brazilian Real ("BRL") and the South African Rand ("ZAR") against the USD.

The tax benefit (expense) on the net activity related to each component of other comprehensive (loss) income was as follows:


(In millions)	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Derivative instruments	$	(12)	$	4	$	(37)	$	6
Pension benefit plans - net	(3)		—		(8)		(3)
Other benefit plans - net	51		—		148		—

Benefit from (provision for) income taxes related to other comprehensive (loss) income items	$	36	$	4	$	103	$	3

A summary of the reclassifications out of accumulated other comprehensive loss is provided as follows:


(In millions)	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Derivative Instruments1:	$	6	$	(22)	$	(9)	$	13
Tax (benefit) expense2	(1)		3		1		(6)
After-tax	$	5	$	(19)	$	(8)	$	7
Amortization of pension benefit plans:
Prior service benefit3,4	$	—	$	—	$	(1)	$	(1)
Actuarial losses3,4	14		1		41		3

Settlement loss3,4	—		—		1		3
Total before tax	$	14	$	1	$	41	$	5
Tax benefit2	(3)		—		(9)		(1)
After-tax	$	11	$	1	$	32	$	4
Amortization of other benefit plans:
Prior service benefit3,4	$	(231)	$	—	$	(692)	$	—
Actuarial gains3,4	23		1		70		1
Curtailment gain	—		—		(1)		—
Total before tax	$	(208)	$	1	$	(623)	$	1
Tax expense2	51		—		148		—
After-tax	$	(157)	$	1	$	(475)	$	1



Unrealized Loss on Investments4	$	—	$	—	$	7	$	—
Tax benefit2	—		—		—		—
After-tax	$	—	$	—	$	7	$	—
Total reclassifications for the period, after-tax	$	(141)	$	(17)	$	(444)	$	12

1.Reflected in cost of goods sold in the interim Consolidated Statements of Operations.

2.Reflected in (benefit from) provision for income taxes from continuing operations in the interim Consolidated Statements of Operations.

3.These accumulated other comprehensive (loss) income components are included in the computation of net periodic benefit credit of the company's pension and other benefit plans. See Note 15 - Pension Plans and Other Post Employment Benefits, for additional information.

4.Reflected in other income - net in the interim Consolidated Statements of Operations.

Pension Plans and Other Post Employment Benefit Plans

9 Months Ended

Sep. 30, 2021

Retirement Benefits [Abstract]

Pension and Other Postretirement Benefits Disclosure [Text Block]

PENSION PLANS AND OTHER POST EMPLOYMENT BENEFITS

The following sets forth the components of the company's net periodic (credit) benefit cost for defined benefit pension plans and other post employment benefits:


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
Defined Benefit Pension Plans:
Service cost	$	7	$	6	$	19	$	19
Interest cost	91		139		273		420
Expected return on plan assets	(228)		(250)		(686)		(750)
Amortization of unrecognized loss	14		1		41		3
Amortization of prior service benefit	—		—		(1)		(1)
Settlement loss	—		—		1		3
Net periodic (credit) benefit cost	$	(116)	$	(104)	$	(353)	$	(306)
Other Post Employment Benefits:
Service cost	$	1	$	—	$	1	$	1
Interest cost	5		16		16		49
Amortization of unrecognized loss	23		1		70		1
Amortization of prior service benefit	(231)		—		(692)		—
Curtailment gain	—		—		(1)		—
Net periodic (credit) benefit cost	$	(202)	$	17	$	(606)	$	51

The entire disclosure for retirement benefits.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section S99
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (o)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (p)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI http://asc.fasb.org/topic&trid=2235017

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (q)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (l)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Financial Instruments

9 Months Ended

Sep. 30, 2021

Financial Instruments Disclosure [Text Block]

FINANCIAL INSTRUMENTS

At September 30, 2021, December 31, 2020 and September 30, 2020, the company had $2,108 million, $2,511 million and $1,986 million, respectively, of held-to-maturity securities (primarily time deposits and money market funds) classified as cash equivalents in the interim Consolidated Balance Sheets, as these securities had maturities of three months or less at the time of purchase; and $103 million, $43 million and $152 million at September 30, 2021, December 31, 2020 and September 30, 2020, respectively, of held-to-maturity securities (primarily time deposits) classified as marketable securities in the interim Consolidated Balance Sheets as these securities had maturities of more than three months to less than one year at the time of purchase. The company’s investments in held-to-maturity securities are held at amortized cost, which approximates fair value. At December 31, 2020, the company had $226 million of available-for-sale debt securities classified as marketable securities in the interim Consolidated Balance Sheet.

Derivative Instruments

Objectives and Strategies for Holding Derivative Instruments

In the ordinary course of business, the company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency and commodity price risks. The company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk.

Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps. The company has not designated any non-derivatives as hedging instruments.

The company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges, and multinational grain exporters. The company is exposed to credit loss in the event of nonperformance by these counterparties. The company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management.

The notional amounts of the company's derivative instruments were as follows:


Notional Amounts (In millions)	September 30, 2021		December 31, 2020		September 30, 2020
Derivatives designated as hedging instruments:
Foreign currency contracts	$	1,227	$	1,164	$	770
Commodity contracts	$	262	$	383	$	51
Derivatives not designated as hedging instruments:
Foreign currency contracts	$	1,164	$	647	$	924
Commodity contracts	$	7	$	—	$	—

Foreign Currency Risk

The company's objective in managing exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency rate changes and to mitigate the exposure of certain investments in foreign subsidiaries against changes in the Euro/USD exchange rate. Accordingly, the company enters into various contracts that change in value as foreign exchange rates change to protect the value of its existing foreign currency-denominated assets, liabilities, commitments, investments and cash flows.

The company uses foreign exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The primary business objective of this hedging program is to maintain an approximately balanced position in foreign currencies so that exchange gains and losses resulting from exchange rate changes, after related tax effects, are minimized. The company also uses foreign currency exchange contracts to offset a portion of the company’s exposure to certain forecasted transactions as well as the translation of foreign currency-denominated earnings. The company also uses commodity contracts to offset risks associated with foreign currency devaluation in certain countries.

Commodity Price Risk

Commodity price risk management programs serve to reduce exposure to price fluctuations on purchases of inventory such as corn and soybeans. The company enters into over-the-counter and exchange-traded derivative commodity instruments to hedge the commodity price risk associated with agricultural commodity exposures.

Derivatives Designated as Cash Flow Hedges

Commodity Contracts

The company enters into over-the-counter and exchange-traded derivative commodity instruments, including options, futures and swaps, to hedge the commodity price risk associated with agriculture commodity exposures.

While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is probable of not occurring.

The following table summarizes the after-tax effect of commodity contract cash flow hedges on accumulated other comprehensive loss:


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
Beginning balance	$	73	$	(16)	$	(16)	$	2
Additions and revaluations of derivatives designated as cash flow hedges	(10)		10		93		(34)
Clearance of hedge results to earnings	(4)		(2)		(18)		24
Ending balance	$	59	$	(8)	$	59	$	(8)

At September 30, 2021, an after-tax net gain of $50 million is expected to be reclassified from accumulated other comprehensive loss into earnings over the next twelve months.

Foreign Currency Contracts

The company enters into forward contracts to hedge the foreign currency risk associated with forecasted transactions within certain foreign subsidiaries.

The following table summarizes the after-tax effect of foreign currency cash flow hedges on accumulated other comprehensive loss:


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
Beginning balance	$	(21)	$	19	$	(17)	$	—
Additions and revaluations of derivatives designated as cash flow hedges	8		4		3		23
Clearance of hedge results to earnings	9		(17)		10		(17)
Ending balance	$	(4)	$	6	$	(4)	$	6

At September 30, 2021, an after-tax net loss of $11 million is expected to be reclassified from accumulated other comprehensive loss into earnings over the next twelve months.

Derivatives Designated as Net Investment Hedges

Foreign Currency Contracts

The company has designated €450 million of forward contracts to exchange EUR as net investment hedges. The purpose of these forward contracts is to mitigate FX exposure related to a portion of the company’s Euro net investments in certain foreign subsidiaries against changes in Euro/USD exchange rates. These hedges will expire and be settled in 2023, unless terminated early at the discretion of the company.

The company elected to apply the spot method in testing for effectiveness of the hedging relationship.

Derivatives not Designated in Hedging Relationships

Foreign Currency Contracts

The company uses foreign exchange contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes. The company also uses foreign currency exchange contracts to offset a portion of the company’s exposure to the translation of certain foreign currency-denominated earnings so that gains and losses on the contracts offset changes in the USD value of the related foreign currency-denominated earnings over the relevant aggregate period.

Commodity Contracts

The company utilizes options, futures and swaps that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as corn and soybeans. The company uses forward agreements, with durations less than one year, to buy and sell USD priced commodities in order to reduce its exposure to currency devaluation for a portion of its local currency cash balances. Counterparties to the forward sales agreements are multinational grain exporters and subject to the company’s financial risk management procedures.

Fair Value of Derivative Instruments

Asset and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the interim Consolidated Balance Sheets. The presentation of the company's derivative assets and liabilities is as follows:


		September 30, 2021
(In millions)	Balance Sheet Location	Gross		Counterparty and Cash Collateral Netting1		Net Amounts Included in the interim Consolidated Balance Sheet
Asset derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other current assets	$	20	$	—	$	20
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	37		(23)		14


Total asset derivatives		$	57	$	(23)	$	34

Liability derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	9	$	—	$	9
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	31		(23)		8

Total liability derivatives		$	40	$	(23)	$	17


		December 31, 2020
(In millions)	Balance Sheet Location	Gross		Counterparty and Cash Collateral Netting1		Net Amounts Included in the Consolidated Balance Sheet
Asset derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other current assets	$	15	$	—	$	15
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	40		(40)		—
Total asset derivatives		$	55	$	(40)	$	15

Liability derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	38	$	—	$	38
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	97		(40)		57
Total liability derivatives		$	135	$	(40)	$	95


		September 30, 2020
(In millions)	Balance Sheet Location	Gross		Counterparty and Cash Collateral Netting1		Net Amounts Included in the interim Consolidated Balance Sheet
Asset derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other current assets	$	24	$	—	$	24
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	101		(75)		26
Commodity contracts	Other current assets	1		—		1
Total asset derivatives		$	126	$	(75)	$	51

Liability derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	12	$	—	$	12
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	84		(69)		15
Commodity contracts	Accrued and other current liabilities	1		—		1
Total liability derivatives		$	97	$	(69)	$	28

1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

Effect of Derivative Instruments


	Amount of Gain (Loss) Recognized in OCI - Pre-Tax1
	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
Derivatives designated as hedging instruments:
Net investment hedges:
Foreign currency contracts	$	10	$	(20)	$	24	$	(16)
Cash flow hedges:
Foreign currency contracts	18		4		12		27
Commodity contracts	(11)		14		117		(46)
Total derivatives designated as hedging instruments	$	17	$	(2)	$	153	$	(35)

1.OCI is defined as other comprehensive income (loss).


	Amount of Gain (Loss) Recognized in Income - Pre-Tax1
	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
Derivatives designated as hedging instruments:
Cash flow hedges:
Foreign currency contracts2	$	(10)	$	19	$	(11)	$	19
Commodity contracts2	4		3		20		(32)
Total derivatives designated as hedging instruments	$	(6)	$	22	$	9	$	(13)
Derivatives not designated as hedging instruments:
Foreign currency contracts3	$	34	$	(6)	$	—	$	173
Foreign currency contracts2	12		3		(16)		19
Commodity contracts2	(1)		—		(18)		9
Total derivatives not designated as hedging instruments	45		(3)		(34)		201
Total derivatives	$	39	$	19	$	(25)	$	188

1.For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.

2.Recorded in cost of goods sold in the interim Consolidated Statements of Operations.

3.Gain recognized in other income (expense) - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 - Supplementary Information, for additional information.

Debt Securities

The estimated fair value of the available-for-sale securities at December 31, 2020 was determined using Level 1 inputs within the fair value hierarchy. Level 1 measurements were based on quoted market prices in active markets for identical assets and liabilities. The available-for-sale securities at December 31, 2020 are held by certain foreign subsidiaries in which the USD is not the functional currency. The fluctuations in foreign exchange are recorded in accumulated other comprehensive loss within the interim Consolidated Statements of Equity. These fluctuations are subsequently reclassified from accumulated other comprehensive loss to earnings in the period in which the marketable securities are sold and the gains and losses on these securities offset a portion of the foreign exchange fluctuations in earnings for the company.

The following table provides the investing results from available-for-sale securities for the nine months ended September 30, 2021:


Investing Results	Nine Months Ended September 30,
(In millions)	2021
Proceeds from sales of available-for-sale securities	$	226

Gross realized losses	$	(7)

Fair Value Measurements

9 Months Ended

Sep. 30, 2021

Fair Value Disclosures [Abstract]

Fair Value Disclosures [Text Block]

FAIR VALUE MEASUREMENTS

The following tables summarize the basis used to measure certain assets and liabilities at fair value on a recurring basis:


September 30, 2021		Significant Other Observable Inputs
(In millions)	Level 1	Level 2
Assets at fair value:

Marketable securities		$	—	$	103
Derivatives relating to:2
Foreign currency		—		57
Equity securities3		75		—
Total assets at fair value		$	75	$	160
Liabilities at fair value:
Derivatives relating to:2
Foreign currency		—		40

Total liabilities at fair value		$	—	$	40


December 31, 2020		Significant Other Observable Inputs

(In millions)	Level 1	Level 2
Assets at fair value:

Marketable securities		$	—	$	43
Debt securities:
U.S. treasuries1		226		—
Derivatives relating to:2
Foreign currency		—		55
Total assets at fair value		$	226	$	98
Liabilities at fair value:
Derivatives relating to:2
Foreign currency		—		135
Total liabilities at fair value		$	—	$	135


September 30, 2020	Significant Other Observable Inputs (Level 2)
(In millions)
Assets at fair value:

Marketable securities	$	152
Derivatives relating to:2
Foreign currency	125
Commodity contracts	1
Total assets at fair value	$	278
Liabilities at fair value:
Derivatives relating to:2
Foreign currency	96
Commodity contracts	1
Total liabilities at fair value	$	97

1. The company's investments in debt securities, which are available-for-sale, are included in "marketable securities" in the interim Consolidated Balance Sheets.

2. See Note 16 - Financial Instruments for the classification of derivatives in the interim Consolidated Balance Sheets.

3. The company's equity securities are included in other assets in the interim Consolidated Balance Sheets.

Segment Reporting Disclosure [Text Block]

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Segment Reporting (Notes)

9 Months Ended

Sep. 30, 2021

Segment Reporting [Abstract]

SEGMENT INFORMATION

Corteva’s reportable segments reflects the manner in which its chief operating decision maker ("CODM") allocates resources and assesses performance, which is at the operating segment level (seed and crop protection). For purposes of allocating resources to the segments and assessing segment performance, segment operating EBITDA is the primary measure used by Corteva’s CODM. The company defines segment operating EBITDA as earnings (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, corporate expenses, non-operating (benefits) costs - net, foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Effective January 1, 2021, on a prospective basis, the company excludes from segment operating EBITDA net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. Non-operating (benefits) costs - net consists of non-operating pension and other post-employment benefit (OPEB) costs, tax indemnification adjustments and environmental remediation and legal costs associated with legacy EID businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense.


As of and for the Three Months Ended September 30, (In millions)	Seed		Crop Protection		Total
2021
Net sales	$	738	$	1,633	$	2,371
Segment operating EBITDA	$	(217)	$	206	$	(11)
Segment assets1	$	23,701	$	12,539	$	36,240

2020
Net sales	$	523	$	1,340	$	1,863
Segment operating EBITDA	$	(282)	$	130	$	(152)
Segment assets1	$	24,372	$	12,593	$	36,965

1. Segment assets at December 31, 2020 were $23,751 million and $13,099 million for Seed and Crop Protection, respectively.


For the Nine Months Ended September 30, (In millions)	Seed		Crop Protection		Total
2021
Net sales	$	7,010	$	5,166	$	12,176
Segment operating EBITDA	$	1,523	$	897	$	2,420

2020
Net sales	$	6,516	$	4,494	$	11,010
Segment operating EBITDA	$	1,255	$	677	$	1,932

Reconciliation to interim Consolidated Financial Statements


Income (loss) from continuing operations after income taxes to segment operating EBITDA (In millions)	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Income (loss) from continuing operations after income taxes	$	36	$	(390)	$	1,667	$	657
(Benefit from) provision for income taxes on continuing operations	(28)		(117)		434		88
Income (loss) from continuing operations before income taxes	8		(507)		2,101		745
Depreciation and amortization	309		285		926		868
Interest income	(19)		(11)		(58)		(38)
Interest expense	8		11		22		35
Exchange (gains) losses - net	(2)		67		47		127
Non-operating benefits - net	(315)		(73)		(941)		(237)

Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges1	(19)				3
Significant items	(21)		49		214		351

Corporate expenses	40		27		106		81
Segment operating EBITDA	$	(11)	$	(152)	$	2,420	$	1,932

1.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. For the three and nine months ended September 30, 2020, the unrealized mark-to-market (loss) gain was $(8) million and $19 million, respectively. Refer to page 57 for further discussion of the company’s Non-GAAP financial measures.


Segment assets to total assets (in millions)	September 30, 2021		December 31, 2020		September 30, 2020
Total segment assets	$	36,240	$	36,850	$	36,965
Corporate assets	4,882		5,799		4,725
Total assets	$	41,122	$	42,649	$	41,690

Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA

The three and nine months ended September 30, 2021 and 2020, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA:


(In millions)	Seed		Crop Protection		Corporate		Total
For the Three Months Ended September 30, 2021
Restructuring and Asset Related Charges - Net 1	$	(9)	$	(8)	$	(9)	$	(26)
Equity securities mark-to-market gain	47		—		—		47
Total	$	38	$	(8)	$	(9)	$	21


(In millions)	Seed		Crop Protection		Corporate		Total
For the Three Months Ended September 30, 2020
Restructuring and Asset Related Charges - Net 1	$	(9)	$	(40)	$	—	$	(49)

Total	$	(9)	$	(40)	$	—	$	(49)


(In millions)	Seed		Crop Protection		Corporate		Total
For the Nine Months Ended September 30, 2021
Restructuring and Asset Related Charges - Net 1	$	(145)	$	(51)	$	(65)	$	(261)
Equity securities mark-to-market gain	47		—		—		47
Total	$	(98)	$	(51)	$	(65)	$	(214)


(In millions)	Seed		Crop Protection		Corporate		Total
For the Nine Months Ended September 30, 2020
Restructuring and Asset Related Charges - Net 1	$	(154)	$	(98)	$	(46)	$	(298)
Loss on Divestiture2	—		(53)		—		(53)
Total	$	(154)	$	(151)	$	(46)	$	(351)

1.Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements for additional information.

2.Includes a loss recorded in other income - net related to the sale of the La Porte site.

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

EID - Basis of Presentation (Notes)	9 Months Ended
EID - Basis of Presentation (Notes)	Sep. 30, 2021
EID [Member]
Entity Information [Line Items]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	BASIS OF PRESENTATION As a result of the Business Realignment and the Internal Reorganization, Corteva, Inc. owns 100% of the outstanding common stock of EID. EID is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Exchange Act. The primary differences between Corteva, Inc. and EID are outlined below: •Preferred Stock - EID has preferred stock outstanding to third parties which is accounted for as a non-controlling interest at the Corteva, Inc. level. Each share of EID Preferred Stock - $4.50 Series and EID Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EID and was unaffected by the Corteva Distribution. •Related Party Loan - EID engaged in a series of debt redemptions during the second quarter of 2019 that were partially funded through an intercompany loan from Corteva, Inc. This was eliminated in consolidation at the Corteva, Inc. level but remains on EID's consolidated financial statements at the standalone level (including the associated interest). •Capital Structure - At September 30, 2021, Corteva, Inc.'s capital structure consists of 730,267,000 issued shares of common stock, par value $0.01 per share. The accompanying footnotes relate to EID only, and not to Corteva, Inc., and are presented to show differences between EID and Corteva, Inc. For the footnotes listed below, refer to the following Corteva, Inc. footnotes: •Note 1 - Summary of Significant Accounting Policies - refer to page 10 of the Corteva, Inc. interim Consolidated Financial Statements •Note 2 - Recent Accounting Guidance - refer to page 10 of the Corteva, Inc. interim Consolidated Financial Statements •Note 3 - Divestitures and Other Transactions - refer to page 10 of the Corteva, Inc. interim Consolidated Financial Statements •Note 4 - Revenue - refer to page 11 of the Corteva, Inc. interim Consolidated Financial Statements •Note 5 - Restructuring and Asset Related Charges - Net - refer to page 14 of the Corteva, Inc. interim Consolidated Financial Statements •Note 6 - Supplementary Information - refer to page 16 of the Corteva, Inc. interim Consolidated Financial Statements •Note 7 - Income Taxes - refer to page 18 of the Corteva, Inc. interim Consolidated Financial Statements •Note 8 - Earnings Per Share of Common Stock - Not applicable for EID •Note 9 - Accounts and Notes Receivable - Net - refer to page 20 of the Corteva, Inc. interim Consolidated Financial Statements •Note 10 - Inventories - refer to page 21 of the Corteva, Inc. interim Consolidated Financial Statements •Note 11 - Other Intangible Assets - refer to page 21 of the Corteva, Inc. interim Consolidated Financial Statements •Note 12 - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities - refer to page 22 of the Corteva, Inc. interim Consolidated Financial Statements. In addition, EID has a related party loan payable to Corteva, Inc.; refer to EID Note 2 - Related Party Transactions, below •Note 13 - Commitments and Contingent Liabilities - refer to page 23 of the Corteva, Inc. interim Consolidated Financial Statements •Note 14 - Stockholders' Equity - refer to page 29 of the Corteva, Inc. interim Consolidated Financial Statements •Note 15 - Pension Plans and Other Post Employment Benefits - refer to page 32 of the Corteva, Inc. interim Consolidated Financial Statements •Note 16 - Financial Instruments - refer to page 32 of the Corteva, Inc. interim Consolidated Financial Statements •Note 17 - Fair Value Measurements - refer to page 38 of the Corteva, Inc. interim Consolidated Financial Statements •Note 18 - Segment Information - Differences exist between Corteva, Inc. and EID; refer to EID Note 3 - Segment Information, below

EID - Related Party Transactions (Notes)	9 Months Ended
EID - Related Party Transactions (Notes)	Sep. 30, 2021
EID [Member]
Related Party Transaction [Line Items]
Related Party Transactions Disclosure [Text Block]	RELATED PARTY TRANSACTIONS Transactions with Corteva In the second quarter of 2019, EID entered into a related party revolving loan from Corteva, Inc., with a maturity date in 2024. As of September 30, 2021, December 31, 2020, and September 30, 2020, the outstanding related party loan balance was $2,443 million, $3,459 million, and $3,712 million respectively (which approximates fair value), with interest rates of 1.52%, 1.62%, and 1.80%, respectively, and is reflected as long-term debt - related party in EID's interim Consolidated Balance Sheets. Additionally, EID has incurred tax deductible interest expense of $11 million and $39 million for the three and nine months ended September 30, 2021, respectively, and $19 million and $82 million for the three and nine months ended September 30, 2020, respectively, associated with the related party loan from Corteva, Inc. As of September 30, 2021, EID had payables to Corteva, Inc., of $61 million and $90 million included in accrued and other current liabilities and other noncurrent obligations, respectively, $92 million at December 31, 2020 included in both accrued and other current liabilities and other noncurrent obligations, respectively, and $110 million and $84 million at September 30, 2020, included in accrued and other current liabilities and other noncurrent obligations, respectively, in the interim Consolidated Balance Sheets related to Corteva's indemnification liabilities to Dow and DuPont per the Separation Agreements (refer to page 10 of the Corteva, Inc. interim Consolidated Financial Statements for further details of the Separation Agreements).

EID Segment FN (Notes)

9 Months Ended

Sep. 30, 2021

Segment Reporting Disclosure [Text Block]

SEGMENT INFORMATION


As of and for the Three Months Ended September 30, (In millions)	Seed		Crop Protection		Total
2021
Net sales	$	738	$	1,633	$	2,371
Segment operating EBITDA	$	(217)	$	206	$	(11)
Segment assets1	$	23,701	$	12,539	$	36,240

2020
Net sales	$	523	$	1,340	$	1,863
Segment operating EBITDA	$	(282)	$	130	$	(152)
Segment assets1	$	24,372	$	12,593	$	36,965

1. Segment assets at December 31, 2020 were $23,751 million and $13,099 million for Seed and Crop Protection, respectively.


For the Nine Months Ended September 30, (In millions)	Seed		Crop Protection		Total
2021
Net sales	$	7,010	$	5,166	$	12,176
Segment operating EBITDA	$	1,523	$	897	$	2,420

2020
Net sales	$	6,516	$	4,494	$	11,010
Segment operating EBITDA	$	1,255	$	677	$	1,932

Reconciliation to interim Consolidated Financial Statements


Income (loss) from continuing operations after income taxes to segment operating EBITDA (In millions)	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Income (loss) from continuing operations after income taxes	$	36	$	(390)	$	1,667	$	657
(Benefit from) provision for income taxes on continuing operations	(28)		(117)		434		88
Income (loss) from continuing operations before income taxes	8		(507)		2,101		745
Depreciation and amortization	309		285		926		868
Interest income	(19)		(11)		(58)		(38)
Interest expense	8		11		22		35
Exchange (gains) losses - net	(2)		67		47		127
Non-operating benefits - net	(315)		(73)		(941)		(237)

Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges1	(19)				3
Significant items	(21)		49		214		351

Corporate expenses	40		27		106		81
Segment operating EBITDA	$	(11)	$	(152)	$	2,420	$	1,932


Segment assets to total assets (in millions)	September 30, 2021		December 31, 2020		September 30, 2020
Total segment assets	$	36,240	$	36,850	$	36,965
Corporate assets	4,882		5,799		4,725
Total assets	$	41,122	$	42,649	$	41,690

Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA

The three and nine months ended September 30, 2021 and 2020, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA:


(In millions)	Seed		Crop Protection		Corporate		Total
For the Three Months Ended September 30, 2021
Restructuring and Asset Related Charges - Net 1	$	(9)	$	(8)	$	(9)	$	(26)
Equity securities mark-to-market gain	47		—		—		47
Total	$	38	$	(8)	$	(9)	$	21


(In millions)	Seed		Crop Protection		Corporate		Total
For the Three Months Ended September 30, 2020
Restructuring and Asset Related Charges - Net 1	$	(9)	$	(40)	$	—	$	(49)

Total	$	(9)	$	(40)	$	—	$	(49)


(In millions)	Seed		Crop Protection		Corporate		Total
For the Nine Months Ended September 30, 2021
Restructuring and Asset Related Charges - Net 1	$	(145)	$	(51)	$	(65)	$	(261)
Equity securities mark-to-market gain	47		—		—		47
Total	$	(98)	$	(51)	$	(65)	$	(214)


(In millions)	Seed		Crop Protection		Corporate		Total
For the Nine Months Ended September 30, 2020
Restructuring and Asset Related Charges - Net 1	$	(154)	$	(98)	$	(46)	$	(298)
Loss on Divestiture2	—		(53)		—		(53)
Total	$	(154)	$	(151)	$	(46)	$	(351)

2.Includes a loss recorded in other income - net related to the sale of the La Porte site.

Segment Reporting Disclosure [Text Block]

SEGMENT INFORMATION

There are no differences in reporting structure or segments between Corteva, Inc. and EID. In addition, there are no differences between Corteva, Inc. and EID segment net sales, segment operating EBITDA, segment assets, or significant items by segment; refer to page 39 of the Corteva, Inc. interim Consolidated Financial Statements for background information on the segments as well as further details regarding segment metrics. The tables below reconcile income from continuing operations after income taxes to segment operating EBITDA, as differences exist between Corteva, Inc. and EID.

Reconciliation to interim Consolidated Financial Statements


Income (loss) from continuing operations after income taxes to segment operating EBITDA (In millions)	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Income (loss) from continuing operations after income taxes	$	27	$	(404)	$	1,637	$	595
(Benefit from) provision for income taxes on continuing operations	(30)		(122)		425		68
Income (loss) from continuing operations before income taxes	(3)		(526)		2,062		663
Depreciation and amortization	309		285		926		868
Interest income	(19)		(11)		(58)		(38)
Interest expense	19		30		61		117
Exchange (gains) losses - net	(2)		67		47		127
Non-operating benefits - net	(315)		(73)		(941)		(237)

Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges1	(19)				3
Significant items	(21)		49		214		351

Corporate expenses	40		27		106		81
Segment operating EBITDA	$	(11)	$	(152)	$	2,420	$	1,932

1.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. For the three and six months ended September 30, 2020, the unrealized mark-to-market (loss) gain was $(8) million and $19 million, respectively.

Summary of Significant Accounting Policies (Policies)	9 Months Ended
Summary of Significant Accounting Policies (Policies)	Sep. 30, 2021
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying unaudited interim Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included. Results for interim periods should not be considered indicative of results for a full year. These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2020, collectively referred to as the “2020 Annual Report.” The interim Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained. Certain reclassifications of prior year's data have been made to conform to current year's presentation. During the first quarter 2020, the company recorded an increase of $40 million to APIC relating to net assets recorded as transferred as part of the 2019 Internal Reorganizations that were retained. Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. Argentina contributes approximately 4 percent to our annual Sales and EBITDA. We remeasure net monetary assets and translate our financial statements utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The ability to draw down Peso cash balances is limited at this time due to government restrictions and market availability of U.S. Dollars. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 6 – Supplementary Information, to the interim Consolidated Financial Statements, and Note 9 – Supplemental Information, to the company's 2020 Annual Report). As of September 30, 2021, a further 10 percent deterioration in the official Peso to USD exchange rate would reduce the USD value of our net monetary assets and negatively impact pre-tax earnings by approximately $20 million. We will continue to assess the implications to our operations and financial reporting.

Recent Accounting Guidance Recent Accounting Guidance (Policies)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Recent Accounting Guidance	Recently Adopted Accounting Guidance In December 2019, the FASB issued Accounting Standards Update ("ASU") 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which was part of the FASB’s Simplification Initiative to identify, evaluate, and improve areas of GAAP for which cost and complexity can be reduced, while maintaining or improving the usefulness of the information provided to users of the financial statements. This ASU amends ASC 740, Income Taxes, by removing certain exceptions to the general principles, and clarifying and amending current guidance. The new standard is effective for fiscal years, and periods within those fiscal years, beginning after December 15, 2020. The company adopted this guidance on January 1, 2021 and it did not have a material impact on the company’s financial position, results of operation or cash flows.

Revenue Revenue Recognition (Policies)	9 Months Ended
Revenue Revenue Recognition (Policies)	Sep. 30, 2021
Revenue from Contract with Customer [Abstract]
Revenue Recognition, Sales of Goods	Products Substantially all of Corteva's revenue is derived from product sales. Product sales consist of sales of Corteva's products to farmers, distributors, and manufacturers. Corteva considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year. However, the company has some long-term contracts which can span multiple years. Revenue from product sales is recognized when the customer obtains control of the company's product, which occurs at a point in time according to shipping terms. Payment terms are generally less than one year from invoicing. The company elected the practical expedient and does not adjust the promised amount of consideration for the effects of a significant financing component when the company expects it will be one year or less between when a customer obtains control of the company's product and when payment is due. The company has elected to recognize shipping and handling activities when control has transferred to the customer as an expense in cost of goods sold. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues. In addition, the company elected the practical expedient to expense any costs to obtain contracts as incurred, as the amortization period for these costs would have been one year or less. The transaction price includes estimates of variable consideration, such as rights of return, rebates, and discounts, that are reductions in revenue. All estimates are based on the company's historical experience, anticipated performance, and the company's best judgment at the time the estimate is made. Estimates of variable consideration included in the transaction price utilize either the expected value method or most likely amount depending on the nature of the variable consideration. These estimates are reassessed each reporting period and are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur upon resolution of uncertainty associated with the variable consideration. The majority of contracts have a single performance obligation satisfied at a point in time and the transaction price is stated in the contract, usually as quantity times price per unit. For contracts with multiple performance obligations, the company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances.
Revenue Recognition, Licenses of Intellectual Property	Licenses of Intellectual PropertyCorteva enters into licensing arrangements with customers under which it licenses its intellectual property. Revenue from the majority of intellectual property licenses is derived from sales-based royalties. Revenue for licensing agreements that contain sales-based royalties is recognized at the later of (i) when the subsequent sale occurs or (ii) when the performance obligation to which some or all of the royalty has been allocated is satisfied.

Revenue (Tables)

9 Months Ended

Sep. 30, 2021

Major Product Line [Member]

Contract Balances


Contract Balances	September 30, 2021		December 31, 2020		September 30, 2020
(In millions)	September 30, 2021		December 31, 2020		September 30, 2020
Accounts and notes receivable - trade1	$	4,744	$	3,917	$	4,638
Contract assets - current2	$	24	$	22	$	21
Contract assets - noncurrent3	$	60	$	54	$	52
Deferred revenue - current	$	692	$	2,662	$	402
Deferred revenue - noncurrent4	$	111	$	116	$	106

1.Included in accounts and notes receivable - net in the interim Consolidated Balance Sheets.

2.Included in other current assets in the interim Consolidated Balance Sheets.

3.Included in other assets in the interim Consolidated Balance Sheets.

4.Included in other noncurrent obligations in the interim Consolidated Balance Sheets.

Disaggregation of Revenue


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
Corn	$	437	$	303	$	4,505	$	4,224
Soybean	157		116		1,494		1,382
Other oilseeds	94		62		661		529
Other	50		42		350		381
Seed	738		523		7,010		6,516
Herbicides	782		583		2,737		2,315
Insecticides	416		395		1,261		1,218
Fungicides	339		261		911		714
Other	96		101		257		247
Crop Protection	1,633		1,340		5,166		4,494
Total	$	2,371	$	1,863	$	12,176	$	11,010

Geography [Domain]

Disaggregation of Revenue


Seed	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
North America1	$	168	$	97	$	4,482	$	4,290
EMEA2	153		117		1,398		1,262
Latin America	334		246		842		668
Asia Pacific	83		63		288		296
Total	$	738	$	523	$	7,010	$	6,516


Crop Protection	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
North America1	$	422	$	390	$	1,693	$	1,528
EMEA2	237		198		1,304		1,163
Latin America	763		559		1,361		1,086
Asia Pacific	211		193		808		717
Total	$	1,633	$	1,340	$	5,166	$	4,494

1.Represents U.S. & Canada.

2.Europe, Middle East, and Africa ("EMEA").

Restructuring and Asset Related Charges (Tables)

9 Months Ended

Sep. 30, 2021

Execute to Win Productivity Program [Domain]

Schedule of Restructuring Reserve by Type of Cost [Table Text Block]


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
Seed	$	—	$	—	$	—	$	3
Crop Protection	4		30		10		85
Corporate expenses	—		—		—		46
Total	$	4	$	30	$	10	$	134


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
Severance and related benefit costs	$	—	$	—	$	—	$	46
Asset related charges	4		30		10		88
Total restructuring and asset related charges - net	$	4	$	30	$	10	$	134


(In millions)	Severance and Related Benefit Costs		Asset Related1		Total
Balance at December 31, 2020	$	53	$	3	$	56
Charges to income from continuing operations	—		10		10
Payments	(24)		(3)		(27)

Asset write-offs	—		(10)		(10)
Balance at September 30, 2021	$	29	$	—	$	29

1.In addition, the company has a liability recorded for asset retirement obligations of $18 million as of September 30, 2021.

2021 Restructuring Actions [Domain]

Schedule of Restructuring Reserve by Type of Cost [Table Text Block]


	Three Months Ended September 30,		Nine Months Ended September 30,
(In millions)	2021		2021
Seed	$	4	$	21
Crop Protection	4		41
Corporate expenses	9		65
Total	$	17	$	127

The following table is a summary of charges incurred related to 2021 Restructuring Actions for the three and nine months ended September 30, 2021:


	Three Months Ended September 30,		Nine Months Ended September 30,
(In millions)	2021		2021
Severance and related benefit costs	$	9	$	58
Asset related charges	7		29
Contract termination charges	1		40
Total restructuring and asset charges - net	$	17	$	127

A reconciliation of the December 31, 2020 to the September 30, 2021 liability balances related to the 2021 Restructuring Actions is summarized below:


(In millions)	Severance and Related Benefit Costs		Asset Related1		Contract Termination2		Total
Balance at December 31, 2020	$	—	$	—	$	—	$	—
Charges to income from continuing operations	58		29		40		127
Payments	(14)		—		(26)		(40)
Asset write-offs	—		(29)		—		(29)
Balance at September 30, 2021	$	44	$	—	$	14	$	58

1.In addition, the company has a liability recorded for asset retirement obligations of $6 million as of September 30, 2021.

2.The liability for contract terminations includes lease obligations. The cash impact of these obligations will be substantially complete by 2022.

Supplementary Information (Tables)

9 Months Ended

Sep. 30, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Other Nonoperating Income (Expense)


Other Income - Net	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
Interest income	$	19	$	11	$	58	$	38
Equity in (losses) / earnings of affiliates - net	(1)		—		4		(3)
Net gain (loss) on sales of businesses and other assets1	1		1		2		(29)
Net exchange gains / (losses)2	2		(67)		(47)		(127)
Non-operating pension and other post employment benefit credit3	326		93		979		275
Miscellaneous income (expense) - net4	31		(8)		17		(34)
Other income - net	$	378	$	30	$	1,013	$	120

Foreign Currency Exchange Gain (Loss)


(In millions)	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Subsidiary Monetary Position Losses
Pre-tax exchange losses	$	(32)	$	(61)	$	(47)	$	(300)
Local tax benefits / (expenses)	3		16		(11)		44
Net after-tax impact from subsidiary exchange losses	$	(29)	$	(45)	$	(58)	$	(256)

Hedging Program Gains
Pre-tax exchange gains (losses)	$	34	$	(6)	$	—	$	173
Tax (expenses) / benefits	(8)		2		—		(41)
Net after-tax impact from hedging program exchange gains (losses)	$	26	$	(4)	$	—	$	132

Total Exchange Losses
Pre-tax exchange gains (losses)	$	2	$	(67)	$	(47)	$	(127)
Tax (expenses) benefits	(5)		18		(11)		3
Net after-tax exchange losses	$	(3)	$	(49)	$	(58)	$	(124)

Restrictions on Cash and Cash Equivalents


(In millions)	September 30, 2021		December 31, 2020		September 30, 2020
Cash and cash equivalents	$	2,779	$	3,526	$	2,768
Restricted cash equivalents	361		347		354
Total cash, cash equivalents and restricted cash equivalents	$	3,140	$	3,873	$	3,122

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2021

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]


Net Income (Loss) for Earnings Per Share Calculations - Basic and Diluted	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
Income (loss) from continuing operations after income taxes	$	36	$	(390)	$	1,667	$	657
Net income attributable to continuing operations noncontrolling interests	2		2		8		18

Income (loss) from continuing operations available to Corteva common stockholders	34		(392)		1,659		639
(Loss) income from discontinued operations available to Corteva common stockholders	(4)		—		(59)		1
Net income (loss) available to common stockholders	$	30	$	(392)	$	1,600	$	640

Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]


Earnings (Loss) Per Share Calculations - Basic	Three Months Ended September 30,				Nine Months Ended September 30,
(Dollars per share)	2021		2020		2021		2020
Earnings (loss) per share of common stock from continuing operations	$	0.05	$	(0.52)	$	2.25	$	0.85
Loss per share of common stock from discontinued operations	(0.01)		—		(0.08)		—
Earnings (loss) per share of common stock	$	0.04	$	(0.52)	$	2.17	$	0.85

Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]


Earnings (Loss) Per Share Calculations - Diluted	Three Months Ended September 30,				Nine Months Ended September 30,
(Dollars per share)	2021		2020		2021		2020
Earnings (loss) per share of common stock from continuing operations	$	0.05	$	(0.52)	$	2.23	$	0.85
Loss per share of common stock from discontinued operations	(0.01)		—		(0.08)		—
Earnings (loss) per share of common stock	$	0.04	$	(0.52)	$	2.15	$	0.85

Share Count Information


Share Count Information	Three Months Ended September 30,		Nine Months Ended September 30,
(Shares in millions)	2021	2020	2021	2020
Weighted-average common shares - basic	733.8	749.5	738.1	749.5
Plus dilutive effect of equity compensation plans1	5.7	—	5.9	2.5

Weighted-average common shares - diluted	739.5	749.5	744.0	752.0
Potential shares of common stock excluded from EPS calculations2	3.0	14.6	3.1	9.7

Accounts and Notes Receivable (Tables)

9 Months Ended

Sep. 30, 2021

Accounts and Notes Receivable [Abstract]

Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]


(In millions)	September 30, 2021		December 31, 2020		September 30, 2020
Accounts receivable – trade1	$	3,336	$	3,754	$	3,231
Notes receivable – trade1,2	1,408		163		1,407
Other3	1,074		1,009		989
Total accounts and notes receivable - net	$	5,818	$	4,926	$	5,627

Accounts Receivable, Allowance for Credit Loss [Table Text Block]


(In millions)
2020
Balance at December 31, 2019	$	174
Net provision for credit losses1	54
Write-offs charged against allowance / other1	(18)
Balance at September 30, 2020	$	210

2021
Balance at December 31, 2020	$	208
Net provision for credit losses	(7)
Write-offs charged against allowance / other	9



Balance at September 30, 2021	$	210

Inventories (Tables)

9 Months Ended

Sep. 30, 2021

Inventory Disclosure [Abstract]

Schedule of Inventory, Current [Table Text Block]


(In millions)	September 30, 2021		December 31, 2020		September 30, 2020
Finished products	$	1,871	$	2,584	$	2,074
Semi-finished products	2,028		1,813		1,878
Raw materials and supplies	518		485		422
Total inventories	$	4,417	$	4,882	$	4,374

Other Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Other Intangible Assets


(In millions)	September 30, 2021						December 31, 2020						September 30, 2020
	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
Intangible assets subject to amortization (Definite-lived):
Germplasm	$	6,265	$	(507)	$	5,758	$	6,265	$	(317)	$	5,948	$	6,265	$	(253)	$	6,012
Customer-related	1,956		(460)		1,496		1,984		(380)		1,604		1,966		(352)		1,614
Developed technology	1,485		(641)		844		1,451		(525)		926		1,463		(499)		964
Trademarks/trade names1	2,012		(152)		1,860		2,019		(99)		1,920		161		(86)		75
Favorable supply contracts	475		(373)		102		475		(302)		173		475		(279)		196
Other2	407		(252)		155		405		(239)		166		405		(233)		172
Total other intangible assets with finite lives	12,600		(2,385)		10,215		12,599		(1,862)		10,737		10,735		(1,702)		9,033

Intangible assets not subject to amortization (Indefinite-lived):
IPR&D	10		—		10		10		—		10		10		—		10
Trade name1													1,871		—		1,871

Total other intangible assets	10		—		10		10		—		10		1,881		—		1,881
Total	$	12,610	$	(2,385)	$	10,225	$	12,609	$	(1,862)	$	10,747	$	12,616	$	(1,702)	$	10,914

2.Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Debt (Tables)

9 Months Ended

Sep. 30, 2021

Debt Instrument [Line Items]

Schedule of Short-term Debt [Table Text Block]


Short-term borrowings and finance lease obligations
(In millions)	September 30, 2021		December 31, 2020		September 30, 2020
Commercial paper	$	802	$	—	$	926
Repurchase facility	550		—		1,175
Other loans - various currencies	18		1		39
Long-term debt payable within one year	1		1		1
Finance lease obligations payable within one year	1		1		1
Total short-term borrowings and finance lease obligations	$	1,372	$	3	$	2,142

Commitments and Contingent Liabilities (Tables)

9 Months Ended

Sep. 30, 2021

Commitments and Contingencies Disclosure [Abstract]

Schedule of Environmental Loss Contingencies by Site [Table Text Block]


	As of September 30, 2021
(In millions)	Indemnification Asset		Accrual balance3		Potential exposure above amount accrued3
Environmental Remediation Stray Liabilities
Chemours related obligations - subject to indemnity1,2	$	156	$	156	$	266
Other discontinued or divested businesses obligations1	10		77		187

Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont2	38		38		64

Environmental remediation liabilities not subject to indemnity	—		72		49

Indemnification liabilities related to the MOU4	9		111		20
Total	$	213	$	454	$	586

1.Represents liabilities that are subject to the $200 million thresholds and sharing arrangements as discussed on page 24, under the header "Corteva Separation Agreement."

2.The company has recorded an indemnification asset related to these accruals, including $40 million related to the Superfund sites.

4.Represents liabilities that are subject to the $150 million thresholds and sharing agreements as discussed on page 23, under the header "Chemours / Performance Chemicals."

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2021

Equity [Abstract]

Schedule of Noncontrolling Interests Represented by Preferred Stock [Table Text Block]


Shares in thousands			Number of Shares
Authorized			23,000
$4.50 Series, callable at $120			1,673
$3.50 Series, callable at $102			700

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]


(In millions)	Cumulative Translation Adjustment1		Derivative Instruments		Pension Benefit Plans		Other Benefit Plans		Unrealized Gain (Loss) on Investments		Total






2020
Balance January 1, 2020	$	(1,944)	$	2	$	(1,247)	$	(81)	$	—	$	(3,270)
Other comprehensive (loss) income before reclassifications	(507)		(23)		(10)		2		—		(538)
Amounts reclassified from accumulated other comprehensive loss	—		7		4		1		—		12
Net other comprehensive (loss) income	(507)		(16)		(6)		3		—		(526)
Balance September 30, 2020	$	(2,451)	$	(14)	$	(1,253)	$	(78)	$	—	$	(3,796)

2021
Balance January 1, 2021	$	(1,970)	$	(67)	$	(1,433)	$	590	$	(10)	$	(2,890)
Other comprehensive (loss) income before reclassifications	(424)		115		(6)		1		3		(311)
Amounts reclassified from accumulated other comprehensive loss	—		(8)		32		(475)		7		(444)
Net other comprehensive (loss) income	(424)		107		26		(474)		10		(755)

Balance September 30, 2021	$	(2,394)	$	40	$	(1,407)	$	116	$	—	$	(3,645)

Tax (Expense) Benefit of Other Comprehensive (Loss) Income


(In millions)	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Derivative instruments	$	(12)	$	4	$	(37)	$	6
Pension benefit plans - net	(3)		—		(8)		(3)
Other benefit plans - net	51		—		148		—

Benefit from (provision for) income taxes related to other comprehensive (loss) income items	$	36	$	4	$	103	$	3

Reclassification out of Accumulated Other Comprehensive (Loss) Income [Table Text Block]


(In millions)	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Derivative Instruments1:	$	6	$	(22)	$	(9)	$	13
Tax (benefit) expense2	(1)		3		1		(6)
After-tax	$	5	$	(19)	$	(8)	$	7
Amortization of pension benefit plans:
Prior service benefit3,4	$	—	$	—	$	(1)	$	(1)
Actuarial losses3,4	14		1		41		3

Settlement loss3,4	—		—		1		3
Total before tax	$	14	$	1	$	41	$	5
Tax benefit2	(3)		—		(9)		(1)
After-tax	$	11	$	1	$	32	$	4
Amortization of other benefit plans:
Prior service benefit3,4	$	(231)	$	—	$	(692)	$	—
Actuarial gains3,4	23		1		70		1
Curtailment gain	—		—		(1)		—
Total before tax	$	(208)	$	1	$	(623)	$	1
Tax expense2	51		—		148		—
After-tax	$	(157)	$	1	$	(475)	$	1



Unrealized Loss on Investments4	$	—	$	—	$	7	$	—
Tax benefit2	—		—		—		—
After-tax	$	—	$	—	$	7	$	—
Total reclassifications for the period, after-tax	$	(141)	$	(17)	$	(444)	$	12

1.Reflected in cost of goods sold in the interim Consolidated Statements of Operations.

2.Reflected in (benefit from) provision for income taxes from continuing operations in the interim Consolidated Statements of Operations.

4.Reflected in other income - net in the interim Consolidated Statements of Operations.

Pension Plans and Other Post Employment Benefit Plans (Tables)

9 Months Ended

Sep. 30, 2021

Retirement Benefits [Abstract]

Schedule of Net Benefit Costs [Table Text Block]


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
Defined Benefit Pension Plans:
Service cost	$	7	$	6	$	19	$	19
Interest cost	91		139		273		420
Expected return on plan assets	(228)		(250)		(686)		(750)
Amortization of unrecognized loss	14		1		41		3
Amortization of prior service benefit	—		—		(1)		(1)
Settlement loss	—		—		1		3
Net periodic (credit) benefit cost	$	(116)	$	(104)	$	(353)	$	(306)
Other Post Employment Benefits:
Service cost	$	1	$	—	$	1	$	1
Interest cost	5		16		16		49
Amortization of unrecognized loss	23		1		70		1
Amortization of prior service benefit	(231)		—		(692)		—
Curtailment gain	—		—		(1)		—
Net periodic (credit) benefit cost	$	(202)	$	17	$	(606)	$	51

Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2021

Derivative [Line Items]

Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]


Notional Amounts (In millions)	September 30, 2021		December 31, 2020		September 30, 2020
Derivatives designated as hedging instruments:
Foreign currency contracts	$	1,227	$	1,164	$	770
Commodity contracts	$	262	$	383	$	51
Derivatives not designated as hedging instruments:
Foreign currency contracts	$	1,164	$	647	$	924
Commodity contracts	$	7	$	—	$	—

Fair Value of Derivatives Instruments


		September 30, 2021
(In millions)	Balance Sheet Location	Gross		Counterparty and Cash Collateral Netting1		Net Amounts Included in the interim Consolidated Balance Sheet
Asset derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other current assets	$	20	$	—	$	20
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	37		(23)		14


Total asset derivatives		$	57	$	(23)	$	34

Liability derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	9	$	—	$	9
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	31		(23)		8

Total liability derivatives		$	40	$	(23)	$	17


		December 31, 2020
(In millions)	Balance Sheet Location	Gross		Counterparty and Cash Collateral Netting1		Net Amounts Included in the Consolidated Balance Sheet
Asset derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other current assets	$	15	$	—	$	15
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	40		(40)		—
Total asset derivatives		$	55	$	(40)	$	15

Liability derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	38	$	—	$	38
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	97		(40)		57
Total liability derivatives		$	135	$	(40)	$	95


		September 30, 2020
(In millions)	Balance Sheet Location	Gross		Counterparty and Cash Collateral Netting1		Net Amounts Included in the interim Consolidated Balance Sheet
Asset derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other current assets	$	24	$	—	$	24
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	101		(75)		26
Commodity contracts	Other current assets	1		—		1
Total asset derivatives		$	126	$	(75)	$	51

Liability derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	12	$	—	$	12
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	84		(69)		15
Commodity contracts	Accrued and other current liabilities	1		—		1
Total liability derivatives		$	97	$	(69)	$	28

Effect of Derivatives


	Amount of Gain (Loss) Recognized in OCI - Pre-Tax1
	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
Derivatives designated as hedging instruments:
Net investment hedges:
Foreign currency contracts	$	10	$	(20)	$	24	$	(16)
Cash flow hedges:
Foreign currency contracts	18		4		12		27
Commodity contracts	(11)		14		117		(46)
Total derivatives designated as hedging instruments	$	17	$	(2)	$	153	$	(35)

1.OCI is defined as other comprehensive income (loss).


	Amount of Gain (Loss) Recognized in Income - Pre-Tax1
	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
Derivatives designated as hedging instruments:
Cash flow hedges:
Foreign currency contracts2	$	(10)	$	19	$	(11)	$	19
Commodity contracts2	4		3		20		(32)
Total derivatives designated as hedging instruments	$	(6)	$	22	$	9	$	(13)
Derivatives not designated as hedging instruments:
Foreign currency contracts3	$	34	$	(6)	$	—	$	173
Foreign currency contracts2	12		3		(16)		19
Commodity contracts2	(1)		—		(18)		9
Total derivatives not designated as hedging instruments	45		(3)		(34)		201
Total derivatives	$	39	$	19	$	(25)	$	188

1.For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.

2.Recorded in cost of goods sold in the interim Consolidated Statements of Operations.

Schedule of Realized Gains (Losses)


Investing Results	Nine Months Ended September 30,
(In millions)	2021
Proceeds from sales of available-for-sale securities	$	226

Gross realized losses	$	(7)

Commodity Contract [Member]

Derivative [Line Items]

After-Tax Effect of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
Beginning balance	$	73	$	(16)	$	(16)	$	2
Additions and revaluations of derivatives designated as cash flow hedges	(10)		10		93		(34)
Clearance of hedge results to earnings	(4)		(2)		(18)		24
Ending balance	$	59	$	(8)	$	59	$	(8)

Foreign Currency Contract [Member]

Derivative [Line Items]

After-Tax Effect of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2021		2020		2021		2020
Beginning balance	$	(21)	$	19	$	(17)	$	—
Additions and revaluations of derivatives designated as cash flow hedges	8		4		3		23
Clearance of hedge results to earnings	9		(17)		10		(17)
Ending balance	$	(4)	$	6	$	(4)	$	6

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2021

Fair Value Disclosures [Abstract]

Fair Value of Assets and Liabilities Measured on Recurring Basis


September 30, 2021		Significant Other Observable Inputs
(In millions)	Level 1	Level 2
Assets at fair value:

Marketable securities		$	—	$	103
Derivatives relating to:2
Foreign currency		—		57
Equity securities3		75		—
Total assets at fair value		$	75	$	160
Liabilities at fair value:
Derivatives relating to:2
Foreign currency		—		40

Total liabilities at fair value		$	—	$	40


December 31, 2020		Significant Other Observable Inputs

(In millions)	Level 1	Level 2
Assets at fair value:

Marketable securities		$	—	$	43
Debt securities:
U.S. treasuries1		226		—
Derivatives relating to:2
Foreign currency		—		55
Total assets at fair value		$	226	$	98
Liabilities at fair value:
Derivatives relating to:2
Foreign currency		—		135
Total liabilities at fair value		$	—	$	135


September 30, 2020	Significant Other Observable Inputs (Level 2)
(In millions)
Assets at fair value:

Marketable securities	$	152
Derivatives relating to:2
Foreign currency	125
Commodity contracts	1
Total assets at fair value	$	278
Liabilities at fair value:
Derivatives relating to:2
Foreign currency	96
Commodity contracts	1
Total liabilities at fair value	$	97

1. The company's investments in debt securities, which are available-for-sale, are included in "marketable securities" in the interim Consolidated Balance Sheets.

2. See Note 16 - Financial Instruments for the classification of derivatives in the interim Consolidated Balance Sheets.

3. The company's equity securities are included in other assets in the interim Consolidated Balance Sheets.

Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2021

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

Reconciliation to interim Consolidated Financial Statements


Income (loss) from continuing operations after income taxes to segment operating EBITDA (In millions)	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Income (loss) from continuing operations after income taxes	$	36	$	(390)	$	1,667	$	657
(Benefit from) provision for income taxes on continuing operations	(28)		(117)		434		88
Income (loss) from continuing operations before income taxes	8		(507)		2,101		745
Depreciation and amortization	309		285		926		868
Interest income	(19)		(11)		(58)		(38)
Interest expense	8		11		22		35
Exchange (gains) losses - net	(2)		67		47		127
Non-operating benefits - net	(315)		(73)		(941)		(237)

Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges1	(19)				3
Significant items	(21)		49		214		351

Corporate expenses	40		27		106		81
Segment operating EBITDA	$	(11)	$	(152)	$	2,420	$	1,932

Schedule of Segment Reporting Information, by Segment [Table Text Block]


As of and for the Three Months Ended September 30, (In millions)	Seed		Crop Protection		Total
2021
Net sales	$	738	$	1,633	$	2,371
Segment operating EBITDA	$	(217)	$	206	$	(11)
Segment assets1	$	23,701	$	12,539	$	36,240

2020
Net sales	$	523	$	1,340	$	1,863
Segment operating EBITDA	$	(282)	$	130	$	(152)
Segment assets1	$	24,372	$	12,593	$	36,965

1. Segment assets at December 31, 2020 were $23,751 million and $13,099 million for Seed and Crop Protection, respectively.


For the Nine Months Ended September 30, (In millions)	Seed		Crop Protection		Total
2021
Net sales	$	7,010	$	5,166	$	12,176
Segment operating EBITDA	$	1,523	$	897	$	2,420

2020
Net sales	$	6,516	$	4,494	$	11,010
Segment operating EBITDA	$	1,255	$	677	$	1,932

Reconciliation of Assets from Segment to Consolidated [Table Text Block]


Segment assets to total assets (in millions)	September 30, 2021		December 31, 2020		September 30, 2020
Total segment assets	$	36,240	$	36,850	$	36,965
Corporate assets	4,882		5,799		4,725
Total assets	$	41,122	$	42,649	$	41,690

Schedule of Additional Segment Details [Table Text Block]


(In millions)	Seed		Crop Protection		Corporate		Total
For the Three Months Ended September 30, 2021
Restructuring and Asset Related Charges - Net 1	$	(9)	$	(8)	$	(9)	$	(26)
Equity securities mark-to-market gain	47		—		—		47
Total	$	38	$	(8)	$	(9)	$	21


(In millions)	Seed		Crop Protection		Corporate		Total
For the Three Months Ended September 30, 2020
Restructuring and Asset Related Charges - Net 1	$	(9)	$	(40)	$	—	$	(49)

Total	$	(9)	$	(40)	$	—	$	(49)


(In millions)	Seed		Crop Protection		Corporate		Total
For the Nine Months Ended September 30, 2021
Restructuring and Asset Related Charges - Net 1	$	(145)	$	(51)	$	(65)	$	(261)
Equity securities mark-to-market gain	47		—		—		47
Total	$	(98)	$	(51)	$	(65)	$	(214)


(In millions)	Seed		Crop Protection		Corporate		Total
For the Nine Months Ended September 30, 2020
Restructuring and Asset Related Charges - Net 1	$	(154)	$	(98)	$	(46)	$	(298)
Loss on Divestiture2	—		(53)		—		(53)
Total	$	(154)	$	(151)	$	(46)	$	(351)

2.Includes a loss recorded in other income - net related to the sale of the La Porte site.

EID Segment FN (Tables)

9 Months Ended

Sep. 30, 2021

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

Reconciliation to interim Consolidated Financial Statements


Income (loss) from continuing operations after income taxes to segment operating EBITDA (In millions)	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Income (loss) from continuing operations after income taxes	$	36	$	(390)	$	1,667	$	657
(Benefit from) provision for income taxes on continuing operations	(28)		(117)		434		88
Income (loss) from continuing operations before income taxes	8		(507)		2,101		745
Depreciation and amortization	309		285		926		868
Interest income	(19)		(11)		(58)		(38)
Interest expense	8		11		22		35
Exchange (gains) losses - net	(2)		67		47		127
Non-operating benefits - net	(315)		(73)		(941)		(237)

Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges1	(19)				3
Significant items	(21)		49		214		351

Corporate expenses	40		27		106		81
Segment operating EBITDA	$	(11)	$	(152)	$	2,420	$	1,932

Reconciliation of Assets from Segment to Consolidated [Table Text Block]


Segment assets to total assets (in millions)	September 30, 2021		December 31, 2020		September 30, 2020
Total segment assets	$	36,240	$	36,850	$	36,965
Corporate assets	4,882		5,799		4,725
Total assets	$	41,122	$	42,649	$	41,690

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]


Income (loss) from continuing operations after income taxes to segment operating EBITDA (In millions)	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Income (loss) from continuing operations after income taxes	$	27	$	(404)	$	1,637	$	595
(Benefit from) provision for income taxes on continuing operations	(30)		(122)		425		68
Income (loss) from continuing operations before income taxes	(3)		(526)		2,062		663
Depreciation and amortization	309		285		926		868
Interest income	(19)		(11)		(58)		(38)
Interest expense	19		30		61		117
Exchange (gains) losses - net	(2)		67		47		127
Non-operating benefits - net	(315)		(73)		(941)		(237)

Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges1	(19)				3
Significant items	(21)		49		214		351

Corporate expenses	40		27		106		81
Segment operating EBITDA	$	(11)	$	(152)	$	2,420	$	1,932

1.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. For the three and six months ended September 30, 2020, the unrealized mark-to-market (loss) gain was $(8) million and $19 million, respectively.

Summary of Significant Accounting Policies Summary of Accounting Policies (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2021	Mar. 31, 2020
Foreign Exchange Impact on Income (Loss) from Continuing Operations	$ 20
Percentage deterioration of the official Peso to USD exchange rate	10.00%
Percentage annual sales and EBITDA	4.00%
Internal Reorganization [Member]
Reclassification of Divisional Equity to APIC		$ 40

Divestitures and Other Transactions Separation Agreements (Details) $ in Millions	Sep. 30, 2021 USD ($)
Accounts and Notes Receivable [Member] \| DuPont de Nemours [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Indemnification Assets	$ 25
Other Assets [Member] \| DuPont de Nemours [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Indemnification Assets	70
Accrued and Other Current Liabilities [Member] \| Dow [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Indemnified Liabilities	54
Other noncurrent obligations \| DuPont de Nemours [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Indemnified Liabilities	76
Other noncurrent obligations \| Dow [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Indemnified Liabilities	$ 14

Divestitures and Other Transactions Other Discontinued Operations (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Income (loss) from discontinued operations after income taxes	$ (4)	$ 0	$ (59)	$ 1

Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(12))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3B
-URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5C
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337

Revenue Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 122	$ 115	$ 114
Minimum [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Maximum [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	6 years

Revenue Contract Balances (Details) - USD ($)
$ in Millions

9 Months Ended

Sep. 30, 2021

Sep. 30, 2020

Dec. 31, 2020

Accounts and notes receivable - trade

^[1]

$ 4,744

$ 4,638

$ 3,917

Contract assets - current

^[2]

Contract assets - noncurrent

^[3]

Deferred revenue recognized during the period

692

402

2,662

2,454

2,195

Accrued and Other Current Liabilities [Member]

Other noncurrent obligations

692

402

2,662

^[4]

$ 111

$ 106

$ 116

[1]	Included in accounts and notes receivable - net in the interim Consolidated Balance Sheets.
[2]	Included in other current assets in the interim Consolidated Balance Sheets.
[3]	Included in other assets in the interim Consolidated Balance Sheets.
[4]	Included in other noncurrent obligations in the interim Consolidated Balance Sheets.

Revenue Disaggregation of Revenue - Principal Product Groups (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Disaggregation of Revenue [Line Items]
Net Sales	$ 2,371	$ 1,863	$ 12,176	$ 11,010
Seed [Member]
Disaggregation of Revenue [Line Items]
Net Sales	738	523	7,010	6,516
Seed [Member] \| Corn [Member]
Disaggregation of Revenue [Line Items]
Net Sales	437	303	4,505	4,224
Seed [Member] \| Soybean [Member]
Disaggregation of Revenue [Line Items]
Net Sales	157	116	1,494	1,382
Seed [Member] \| Other oilseeds [Member]
Disaggregation of Revenue [Line Items]
Net Sales	94	62	661	529
Seed [Member] \| Other [Member]
Disaggregation of Revenue [Line Items]
Net Sales	50	42	350	381
Crop Protection [Member]
Disaggregation of Revenue [Line Items]
Net Sales	1,633	1,340	5,166	4,494
Crop Protection [Member] \| Other [Member]
Disaggregation of Revenue [Line Items]
Net Sales	96	101	257	247
Crop Protection [Member] \| Herbicides [Member]
Disaggregation of Revenue [Line Items]
Net Sales	782	583	2,737	2,315
Crop Protection [Member] \| Insecticides [Member]
Disaggregation of Revenue [Line Items]
Net Sales	416	395	1,261	1,218
Crop Protection [Member] \| Fungicides [Member]
Disaggregation of Revenue [Line Items]
Net Sales	$ 339	$ 261	$ 911	$ 714

Revenue Disaggregation of Revenue - Geography (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2021

Sep. 30, 2020

Sep. 30, 2021

Sep. 30, 2020

$ 2,371

$ 1,863

$ 12,176

$ 11,010

Seed [Member]

Seed [Member] | North America

738

523

7,010

6,516

^[1]

168

4,482

4,290

Seed [Member] | EMEA

Seed [Member] | Latin America

^[2]

153

117

1,398

1,262

Seed [Member] | Asia Pacific

334

246

842

668

288

296

Crop Protection [Member]

Crop Protection [Member] | North America

1,633

1,340

5,166

4,494

Crop Protection [Member] | EMEA

^[1]

422

390

1,693

1,528

Crop Protection [Member] | Latin America

^[2]

237

198

1,304

1,163

Crop Protection [Member] | Asia Pacific

763

559

1,361

1,086

$ 211

$ 193

$ 808

$ 717

[1]	Represents U.S. & Canada.
[2]	Europe, Middle East, and Africa ("EMEA").

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Restructuring and Asset Related Charges - 2021 Restructuring Activities (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2021

Sep. 30, 2020

Sep. 30, 2021

Sep. 30, 2020

Dec. 31, 2020

2021 Restructuring Actions [Domain]

$ 26

$ 49

$ 261

$ 298

Asset Retirement Obligation

150

(40)

(29)

$ 0

Severance and Related Benefit Costs | 2021 Restructuring Actions [Domain]

127

(14)

^[1]

^[1]

(29)

^[1]

Asset Retirement Obligation Costs [Member] | 2021 Restructuring Actions [Domain]

^[1]

Contract Termination | 2021 Restructuring Actions [Domain]

Costs Associated with Exit and Disposal Activities | 2021 Restructuring Actions [Domain]

^[2]

(26)

^[2]

^[2]

$ 0

Seed [Member] | 2021 Restructuring Actions [Domain]

^[2]

Crop Protection [Member] | 2021 Restructuring Actions [Domain]

Corporate Segment | 2021 Restructuring Actions [Domain]

Equity in (losses) / earnings of affiliates - net

$ 9

$ 65

[1]	In addition, the company has a liability recorded for asset retirement obligations of $6 million as of September 30, 2021.
[2]	The liability for contract terminations includes lease obligations. The cash impact of these obligations will be substantially complete by 2022

Restructuring and Asset Related Charges Execute to Win Productivity Program (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		15 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Mar. 31, 2021
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net	$ 26	$ 49	$ 261	$ 298
Execute to Win Productivity Program [Domain]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Beginning Balance			56
Payments for Restructuring			(27)
Asset write-offs and adjustments			(10)
Asset Retirement Obligation	18		18
Restructuring Reserve, Ending Balance	29		29
Restructuring and Asset related charges, net	4	30	10	134
Restructuring and Asset Related Charges - Net					$ 186
Severance and Related Benefit Costs \| Execute to Win Productivity Program [Domain]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Beginning Balance			53
Payments for Restructuring			(24)
Asset write-offs and adjustments			0
Restructuring Reserve, Ending Balance	29		29
Restructuring and Asset related charges, net	0	0	0	46
Restructuring and Asset Related Charges - Net					63
Asset Related Charges [Member] \| Execute to Win Productivity Program [Domain]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Beginning Balance			3
Payments for Restructuring			(3)
Asset write-offs and adjustments			(10)
Restructuring Reserve, Ending Balance	0		0
Restructuring and Asset related charges, net	4	30	10	88
Restructuring and Asset Related Charges - Net					$ 123
Seed [Member] \| Execute to Win Productivity Program [Domain]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net	0	0	0	3
Crop Protection [Member] \| Execute to Win Productivity Program [Domain]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net	4	30	10	85
Corporate \| Execute to Win Productivity Program [Domain]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net	$ 0	$ 0	$ 0	$ 46

Restructuring and Asset Related Charges Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Other Asset Related [Member]
Restructuring Cost and Reserve [Line Items]
Accelerated Prepaid Royalty Amortization Expense	$ 5	$ 124

Related Party Transactions Dow Intercompany Transactions (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Corteva [Member] \| EID [Member]
Related Party Transaction [Line Items]
Interest Expense, Related Party	$ 11	$ 19	$ 39	$ 82

Supplementary Information Other Income (Expense) - Net (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2021

Sep. 30, 2020

Sep. 30, 2021

Sep. 30, 2020

$ (1)

$ 0

$ 4

$ (3)

Net gain (loss) on sales of businesses and other assets

^[1]

(29)

Non-operating pension and other post employment benefit credit

^[2]

(67)

(47)

(127)

^[3]

326

979

275

Miscellaneous expenses - net

^[4]

(8)

(34)

Other income - net

378

1,013

120

Hedging Program [Member] | Argentine Peso Devaluation [Member]

(6)

173

Subsidiary Monetary Position

(16)

(26)

(53)

(56)

(32)

(61)

(47)

(300)

Non-operating pension and other post employment benefit credit

(2)

127

(315)

(73)

(941)

(237)

Gain (Loss) on Disposition of Assets

^[5]

(53)

Segment Reconciling Items [Member] | Crop Protection [Member]

$ (19)

$ (11)

$ (58)

(38)

Gain (Loss) on Disposition of Assets

(53)

Sale of JV [Member] | Segment Reconciling Items [Member] | Crop Protection [Member]

Gain (Loss) on Disposition of Assets

^[5]

$ (53)

[1]	The nine months ended September 30, 2020 includes a loss of $(53) million relating to the sale of the La Porte site, for which the company signed an agreement in 2020, and closed during the first quarter of 2021.
[2]	Includes net pre-tax exchange losses of $(16) million and $(53) million associated with the devaluation of the Argentine peso for the three and nine months ended September 30, 2021, respectively, and $(26) million and $(56) million for the three and nine months ended September 30, 2020, respectively.
[3]	Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement loss).
[4]	Miscellaneous expense - net for the three and nine months ended September 30, 2021 and 2020 includes losses on sale of receivables, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, and other items. Miscellaneous expense - net for the three and nine months ended September 30, 2021 also includes a gain from remeasurement of an equity investment and for the nine months ended September 30, 2021 includes realized losses on sale of available-for-sale securities.
[5]	Includes a loss recorded in other income - net related to the sale of the La Porte site.

Supplementary Information Foreign Currency Exchange Gain (Loss) (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2021

Sep. 30, 2020

Sep. 30, 2021

Sep. 30, 2020

Foreign Currency Exchange Gain (Loss) [Line Items]

Pre-tax exchange (losses) gains - net

^[1]

$ 2

$ (67)

$ (47)

$ (127)

Foreign Currency Transaction (Loss) Gain Tax (Expense) Benefit

(5)

(11)

Foreign Currency Transaction (Loss) Gain After Tax

(3)

(49)

(58)

(124)

Subsidiary Monetary Position

Foreign Currency Exchange Gain (Loss) [Line Items]

Pre-tax exchange (losses) gains - net

(32)

(61)

(47)

(300)

Foreign Currency Transaction (Loss) Gain Tax (Expense) Benefit

(11)

Foreign Currency Transaction (Loss) Gain After Tax

(29)

(45)

(58)

(256)

Foreign Currency Exchange Gain (Loss) [Line Items]

Pre-tax exchange (losses) gains - net

(6)

173

Foreign Currency Transaction (Loss) Gain Tax (Expense) Benefit

(8)

(41)

Foreign Currency Transaction (Loss) Gain After Tax

$ 26

$ (4)

$ 0

$ 132

[1]

Includes net pre-tax exchange losses of $(16) million and $(53) million associated with the devaluation of the Argentine peso for the three and nine months ended September 30, 2021, respectively, and $(26) million and $(56) million for the three and nine months ended September 30, 2020, respectively.

Supplementary Information Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Millions

Sep. 30, 2021

Dec. 31, 2020

Sep. 30, 2020

Dec. 31, 2019

Restricted Cash and Cash Equivalents Items [Line Items]

Cash and cash equivalents

$ 2,779

$ 3,526

$ 2,768

Cash, Cash Equivalents and Restricted Cash, Total Company

3,140

^[1]

3,873

3,122

^[1]

$ 2,173

Other Current Assets [Member]

Restricted Cash and Cash Equivalents Items [Line Items]

Restricted Cash

$ 361

$ 347

$ 354

[1]	See page 17 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in interim Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows.

Income Taxes Income Tax Narrative (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2020
Income Tax Disclosure [Abstract]
Net tax benefits associated with changes in accruals	$ 32	$ 58
Tax Benefit associated with U.S. Research and Development Tax Credits	$ 22	$ 22
Tax benefit related to an elective change in accounting method for the impact of the Act's foreign tax provisions			$ 51
Tax benefit related to the impact of recent tax law enactment in foreign jurisdictions			$ 14

Earnings Per Share Net Income for Earnings Per Share Calculations - Basic and Diluted (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Earnings Per Share [Abstract]
Income (loss) from continuing operations after income taxes	$ 36	$ (390)	$ 1,667	$ 657
Net income (loss) Attributable to Noncontrolling Interest, Continuing Operations	2	2	8	18
Net income (loss) from Continuing Operations Available to Common Shareholders	34	(392)	1,659	639
Income (loss) from discontinued operations after income taxes	(4)	0	(59)	1
Net income (loss) Available to Common Stockholders	$ 30	$ (392)	$ 1,600	$ 640

Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Earnings Per Share Earnings Per Share Calculations - Basic (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Earnings Per Share [Abstract]
Basic earnings (loss) per share of common stock from continuing operations	$ 0.05	$ (0.52)	$ 2.25	$ 0.85
Basic earnings (loss) per share of common stock from discontinued operations	$ (0.01)	$ 0	$ (0.08)	$ 0
Basic earnings (loss) per share of common stock	$ 0.04	$ (0.52)	$ 2.17	$ 0.85

The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(11))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(20))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-03(13))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868656-224227

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Earnings Per Share Earnings Per Share Calculations - Diluted (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Earnings Per Share [Abstract]
Diluted earnings (loss) per share of common stock from continuing operations	$ 0.05	$ (0.52)	$ 2.23	$ 0.85
Diluted earnings (loss) per share of common stock from discontinued operations	$ (0.01)	$ 0	$ (0.08)	$ 0
Diluted earnings (loss) per share of common stock	$ 0.04	$ (0.52)	$ 2.15	$ 0.85

The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(11))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-03(13))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868656-224227

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Weighted Average Common Shares - basic

Earnings Per Share Share Count Information (Details) - shares

3 Months Ended

9 Months Ended

Sep. 30, 2021

Sep. 30, 2020

Sep. 30, 2021

Sep. 30, 2020

Dec. 31, 2020

Earnings Per Share [Line Items]

733,800,000

749,500,000

738,100,000

749,500,000

Dilutive effect of equity compensation plans

^[1]

5,700,000

5,900,000

2,500,000

Weighted Average Common Shares - diluted

739,500,000

749,500,000

744,000,000.0

752,000,000.0

Potential shares of common stock excluded from EPS calculations

^[2]

3,000,000.0

14,600,000

3,100,000

9,700,000

Common Stock, Shares Authorized

1,666,667,000

[1]	Diluted earnings per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.
[2]	These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been anti-dilutive.

Accounts and Notes Receivable (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2021

Sep. 30, 2020

Sep. 30, 2021

Sep. 30, 2020

Dec. 31, 2020

Dec. 31, 2019

Accounts, Notes, Loans and Financing Receivable [Line Items]

Accounts Receivable - trade

^[1]

$ 3,336

$ 3,231

$ 3,336

$ 3,231

$ 3,754

Notes receivable - trade

^[1],[2]

1,408

1,407

1,408

1,407

163

Other

^[3]

1,074

989

1,074

989

1,009

Accounts and notes receivable - net

5,818

5,627

5,818

5,627

4,926

Accounts Receivable, Allowance for Credit Loss, Current

210

208

$ 174

Due from Affiliates

106

Factoring Agreement [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Trade Receivables Sold

257

221

Trade receivables sold the remain outstanding with an element of recourse

173

178

173

178

$ 157

Loss on Sale of Accounts Receivable

$ 11

$ 54

$ 49

[1]	Accounts receivable – trade and notes receivable - trade are net of allowances of $210 million at September 30, 2021, $208 million at December 31, 2020, and $210 million at September 30, 2020. Allowances are equal to the estimated uncollectible amounts and are based on the expected credit losses and were developed using a loss-rate method.
[2]	Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of September 30, 2021, December 31, 2020, and September 30, 2020 there were no significant impairments related to current loan agreements.
[3]	Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 10 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $84 million, $106 million, and $92 million as of September 30, 2021, December 31, 2020, and September 30, 2020, respectively.

Accounts and Notes Receivable Allowance Rollforward (Details) - USD ($)
$ in Millions

9 Months Ended

Sep. 30, 2021

Sep. 30, 2020

Receivables [Abstract]

Accounts Receivable, Allowance for Credit Loss, Beginning Balance

$ 208

$ 174

Net provision for credit losses1

(7)

^[1]

Write-offs charged against allowance / other1

(18)

Other deductions against allowance

Accounts Receivable, Allowance for Credit Loss, Ending Balance

$ 210

[1]

Prior year classifications in the changes in the allowance for doubtful receivables have been revised. Revisions did not impact the amount of the provision or the allowance for doubtful receivables recorded in the interim Consolidated Statements of Operations or the interim Consolidated Balance Sheets.

Inventories Schedule of Inventory (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020
Inventory [Line Items]
Finished Products	$ 1,871	$ 2,584	$ 2,074
Semi-finished Products	2,028	1,813	1,878
Raw Materials and Supplies	518	485	422
Total inventories	$ 4,417	$ 4,882	$ 4,374

Property, Plant and Equipment Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 8,270	$ 8,253	$ 7,985
Accumulated Depreciation	$ (3,960)	$ (3,857)	$ (3,712)

Other Intangible Assets Other Intangible Assets (Details) - USD ($)
$ in Millions

3 Months Ended

Sep. 30, 2020

Sep. 30, 2021

Dec. 31, 2020

Acquired Finite-Lived Intangible Assets [Line Items]

Finite-Lived Intangible Assets, Accumulated Amortization

$ 10,735

$ 12,600

$ 12,599

(1,702)

(2,385)

(1,862)

Indefinite-lived Intangible Assets (Excluding Goodwill)

9,033

10,215

10,737

1,881

Intangible Assets, Gross (Excluding Goodwill)

12,616

12,610

12,609

Total other intangible assets

10,914

10,225

10,747

Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)

Impairment of Intangible Assets Indefinite lived Excluding Goodwill After Tax

Trade Names [Member]

Acquired Finite-Lived Intangible Assets [Line Items]

Indefinite-lived Intangible Assets (Excluding Goodwill)

^[1]

1,871

In Process Research and Development [Member]

Acquired Finite-Lived Intangible Assets [Line Items]

Indefinite-lived Intangible Assets (Excluding Goodwill)

Germplasm [Member]

Acquired Finite-Lived Intangible Assets [Line Items]

Finite-Lived Intangible Assets, Accumulated Amortization

6,265

(253)

(507)

(317)

Acquired Finite-Lived Intangible Assets [Line Items]

6,012

5,758

5,948

Finite-Lived Intangible Assets, Accumulated Amortization

1,966

1,956

1,984

(352)

(460)

(380)

Developed Technology Rights [Member]

1,614

1,496

1,604

Acquired Finite-Lived Intangible Assets [Line Items]

Finite-Lived Intangible Assets, Accumulated Amortization

1,463

1,485

1,451

(499)

(641)

(525)

Trademarks and Trade Names [Member]

964

844

926

Acquired Finite-Lived Intangible Assets [Line Items]

Finite-Lived Intangible Assets, Accumulated Amortization

^[1]

161

2,012

2,019

^[1]

(86)

(152)

(99)

Favorable Supply Contract [Member]

^[1]

1,860

1,920

Acquired Finite-Lived Intangible Assets [Line Items]

Finite-Lived Intangible Assets, Accumulated Amortization

475

(279)

(373)

(302)

Other Intangible Assets [Member]

196

102

173

Acquired Finite-Lived Intangible Assets [Line Items]

Finite-Lived Intangible Assets, Accumulated Amortization

^[2]

405

407

405

^[2]

(233)

(252)

(239)

^[2]

$ 172

$ 155

$ 166

[1]

Beginning on October 1, 2020, the company changed its indefinite life assertion of its trade name asset to definite lived with a useful life of 25 years. This change is the result of the launch of BrevantTM seed in the retail channel in the U.S. Prior to changing the useful life of the trade name asset, the company tested the asset for impairment under ASC 350- Intangibles, Goodwill and Other, concluding the asset was not impaired.

[2]

Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

Other Intangible Assets Future Amortization Expense (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 180	$ 162	$ 543	$ 501
Continuing Operations [Member]
Finite-Lived Intangible Assets [Line Items]
Pre-tax amortization expense, remainder of 2021	178		178
Pre-tax amortization expense, 2022	700		700
Pre-tax amortization expense, 2023	620		620
Pre-tax amortization expense, 2024	606		606
Pre-tax amortization expense, 2025	569		569
Pre-tax amortization expense, 2026	$ 558		$ 558

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Short-term borrowings and finance lease obligations (Details) - USD ($) $ in Millions	Sep. 30, 2021	Feb. 09, 2021	Dec. 31, 2020	Sep. 30, 2020
Short-term Debt [Line Items]
Long-term Debt Payable within one year	$ 1		$ 1	$ 1
Finance Lease, Liability, Current	1		1	1
Short-term borrowings and finance lease obligations	1,372		3	2,142
Commercial Paper [Member]
Short-term Debt [Line Items]
Short-term borrowings	802		0	926
Securities Sold under Agreements to Repurchase [Member]
Short-term Debt [Line Items]
Short-term borrowings		$ 1,000
Other loans - various currencies [Member]
Short-term Debt [Line Items]
Short-term borrowings	18		1	39
Repurchase Agreements [Member] \| Securities Sold under Agreements to Repurchase [Member]
Short-term Debt [Line Items]
Short-term borrowings	$ 550		$ 0	$ 1,175

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Long-term Debt (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	May 31, 2020
Debt Instrument [Line Items]
Long-term Debt Payable within one year	$ 1	$ 1	$ 1
Senior Notes Due 2025 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				1.70%
Long-term Debt, Gross				$ 500
Senior Notes Due 2030 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				2.30%
Long-term Debt, Gross				$ 500
Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value	$ 1,134	$ 1,168	$ 1,164

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Repurchase Facility and Revolving Credit Facilities (Details) $ in Millions	9 Months Ended		36 Months Ended	60 Months Ended
	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Nov. 13, 2021	Nov. 13, 2023	Feb. 09, 2021 USD ($)	Dec. 31, 2020 USD ($)	Jun. 30, 2020 USD ($)	Nov. 13, 2018 USD ($)
Line of Credit Facility [Line Items]
Proceeds from debt	$ 419	$ 2,434
Repayments of Long-term Debt	1	879
Revolving Credit Facilities due 2024 [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity								$ 3,000
Revolving Credit Facilities due 2022 [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity								$ 3,000
Long-term Line of Credit							$ 500
Line of Credit Facility, Remaining Borrowing Capacity	3,000
Securities Sold under Agreements to Repurchase [Member]
Line of Credit Facility [Line Items]
Short-term borrowings					$ 1,000
Percentage of outstanding amounts borrowed utilized as collateral					105.00%
Interest rate in addition to LIBOR					0.85%
Securities Sold under Agreements to Repurchase [Member] \| Repurchase Agreements [Member]
Line of Credit Facility [Line Items]
Short-term borrowings	550	$ 1,175				$ 0
Revolving Credit Facilities due 2022 [Member]
Line of Credit Facility [Line Items]
Ratio of Indebtedness to Net Capital								0.60
Accounts and Notes Receivable [Member] \| Securities Sold under Agreements to Repurchase [Member] \| Repurchase Agreements [Member]
Line of Credit Facility [Line Items]
Pledged Financial Instruments, Not Separately Reported, Loans Receivable Pledged as Collateral	$ 578
Forecast [Member] \| Revolving Credit Facilities due 2024 [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Term				5 years
Forecast [Member] \| Revolving Credit Facilities due 2022 [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Term			3 years

Commitments and Contingent Liabilities Guarantee Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020
Guarantor Obligations [Line Items]
Guarantee Obligations	$ 107	$ 94	$ 96
Factoring Agreement [Member]
Guarantor Obligations [Line Items]
Guarantee Obligations	22	17	20
Agreements with lenders to provide financing for select customers [Member]
Guarantor Obligations [Line Items]
Accounts Receivable, after Allowance for Credit Loss	$ 615	$ 16	$ 637

Commitments and Contingent Liabilities Chemours (Details) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021 USD ($)	Jun. 30, 2018 USD ($)	Sep. 30, 2021 USD ($)	Mar. 31, 2029 USD ($)	Dec. 31, 2028 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2017 lawsuits
Settlement Agreement
Loss Contingencies [Line Items]
Income (loss) from discontinued operations before income taxes	$ 11.0
Performance Chemicals
Loss Contingencies [Line Items]
Income (loss) from discontinued operations before income taxes	8.0		$ 45.0
PFAS [Member]
Loss Contingencies [Line Items]
Escrow Account Balance					$ 700.0
PFAS [Member] \| Maximum [Member]
Loss Contingencies [Line Items]
Cost Sharing Arrangement Term			20 years
Qualified Spend and Escrow Account Contribution Threshold	4,000.0		$ 4,000.0
Corteva and DuPont stray liability threshold for PFAS	300.0		300.0
PFOA Matters: Multi-District Litigation [Member]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party		$ 670.7
Lawsuits alleging personal injury filed \| lawsuits							3,550
DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Amount credited to each company's threshold	$ 150.0		$ 150.0
Chemours [Member] \| PFAS [Member]
Loss Contingencies [Line Items]
Annual Escrow Deposit						$ 100.0
Annual Escrow Deposit, remainder of period				$ 50.0
Chemours [Member] \| PFAS [Member] \| Maximum [Member]
Loss Contingencies [Line Items]
Total Escrow Deposit Amount				500.0
Corteva [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage	29.00%		29.00%
Corteva [Member] \| PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50.00%		50.00%
Corteva [Member] \| DuPont de Nemours [Member] \| PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50.00%		50.00%
Annual Escrow Deposit						$ 100.0
Annual Escrow Deposit, remainder of period				50.0
Escrow Account Deposit Percentage	50.00%		50.00%
Corteva [Member] \| DuPont de Nemours [Member] \| PFAS [Member] \| Maximum [Member]
Loss Contingencies [Line Items]
Qualified Spend and Escrow Account Contribution Threshold	$ 2,000.0		$ 2,000.0
Total Escrow Deposit Amount				$ 500.0
DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage	71.00%		71.00%
DuPont de Nemours [Member] \| PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50.00%		50.00%
DuPont de Nemours [Member] \| DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Corteva and DuPont stray liability threshold for PFAS	$ 200.0		$ 200.0

Commitments and Contingent Liabilities DuPont (Details)	Sep. 30, 2021 USD ($)
PFAS [Member] \| Minimum [Member]
Loss Contingencies [Line Items]
Corteva and DuPont stray liability threshold for PFAS	$ 1
PFAS [Member] \| Minimum [Member] \| Once $300 million threshold is met [Member]
Loss Contingencies [Line Items]
De minimis threshold	1,000,000
PFAS [Member] \| Maximum [Member]
Loss Contingencies [Line Items]
Corteva and DuPont stray liability threshold for PFAS	300,000,000
DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Amount credited to each company's threshold	$ 150,000,000
Corteva [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage	29.00%
Corteva [Member] \| PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50.00%
Corteva [Member] \| DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability threshold	$ 200,000,000
Corteva [Member] \| DuPont de Nemours [Member] \| PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50.00%
DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage	71.00%
DuPont de Nemours [Member] \| PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50.00%
DuPont de Nemours [Member] \| DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability threshold	$ 200,000,000
Corteva and DuPont stray liability threshold for PFAS	$ 200,000,000

Commitments and Contingent Liabilities PFOA / Leach Settlement (Details)	3 Months Ended	9 Months Ended	12 Months Ended
	Jun. 30, 2018 USD ($)	Sep. 30, 2021 USD ($) lawsuits	Dec. 31, 2004 USD ($)	Dec. 31, 2017 lawsuits	Jan. 01, 2012
MDL Settlement [Domain]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party		$ 83,000,000
DuPont de Nemours and Corteva Contribution to MDL Settlement
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party		27,000,000
Payments for Legal Settlements		27,000,000
PFAS [Member] \| Chemours [Member]
Loss Contingencies [Line Items]
Chemours Contribution to MDL Settlement		0.50
PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Binding Settlement Agreement Class Size			80,000
Loss Contingency, Number Of Water Districts Receiving Water Treatment					6
Litigation Settlement, Liability For Medical Monitoring Program, Threshold			$ 235,000,000
Litigation Settlement, Medical Monitoring Program, Escrow Account, Disbursements To Date		2,000,000
Escrow Balance		$ 1,000,000
PFOA Matters: Drinking Water Actions [Member] \| WEST VIRGINIA AND OHIO [Domain] \| Settled Litigation
Loss Contingencies [Line Items]
Loss Contingency, Claims Settled, Number \| lawsuits		95,000,000
PFOA Matters: Drinking Water Actions [Member] \| WEST VIRGINIA AND OHIO [Domain] \| Compensatory damages [Member]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party		$ 40,000,000
PFOA Matters: Drinking Water Actions [Member] \| WEST VIRGINIA AND OHIO [Domain] \| Loss of consortium [Member]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party		$ 10,000,000
PFOA Matters: Multi-District Litigation [Member]
Loss Contingencies [Line Items]
Disease Categories for MDL		6
Lawsuits alleging personal injury filed \| lawsuits				3,550
Litigation Settlement, Amount Awarded to Other Party	$ 670,700,000

Commitments and Contingent Liabilities Other PFOA Matters / Fayetteville (Details) $ in Millions	9 Months Ended
	Sep. 30, 2021 USD ($) lawsuits
Firefighting Foam [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number \| lawsuits	1,760
Personal injury cases [Member] \| Firefighting Foam [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number	1,600
Municipal water districts \| Firefighting Foam [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number	96
Chemours Contribution to MDL Settlement
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party	$ 29.0
NEW YORK \| PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number	50
NEW JERSEY \| PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number \| lawsuits	2
NEW JERSEY \| Natural Resources Damages [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number	4
OHIO \| PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number \| lawsuits	3
NORTH CAROLINA \| PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Number of Property Owners	100
Loss Contingency, Number of Additional Plaintiffs	100
DELAWARE \| Natural Resources Damages [Member] \| Corteva [Member] \| DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Threshold for payments to fund the NRST Trust	$ 50.0
Supplemental payment threshold	$ 25.0
Period for supplemental payment	8 years
Corteva and DuPont Share of NRST Trust Payment	$ 12.5
DELAWARE \| Natural Resources Damages [Member] \| Chemours [Member]
Loss Contingencies [Line Items]
Chemours share of payment to NRST Trust	$ 25.0
Chemours share of payment to NRST Trust, percentage	50.00%
NETHERLANDS \| PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number \| lawsuits	4
Alabama Water Utility [Member] \| Natural Resources Damages [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number	1

Commitments and Contingent Liabilities Environmental (Details)
$ in Millions

Sep. 30, 2021

USD ($)

$ 213

Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual

454

^[1]

586

^[1]

156

^[2],[3]

Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual

156

^[1],[2],[3]

266

^[1],[2],[3]

Discontinued Operations [Member]

Other discontinued or divested business obligations [Member]

^[2]

Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual

^[1],[2]

187

^[1],[2]

Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont [Member]

^[3]

Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual

^[1],[3]

^[1],[3]

Not subject to indemnification [Member]

Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual

^[1]

^[1]

Indemnification liabilities related to the MOU

^[4]

Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual

111

^[1],[4]

^[1],[2],[4]

DuPont de Nemours [Member] | DuPont de Nemours [Member]

Stray liability threshold

200

Superfund Sites [Member]

Superfund Sites [Member] | Chemours [Member] | Indemnification Agreement [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

$ 40

[1]	Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates. Accrual balances includes $67 million for remediation of Superfund sites.4.Represents liabilities that are subject to the $150 million thresholds and sharing agreements as discussed on page 23, under the header "Chemours / Performance Chemicals."
[2]	Represents liabilities that are subject to the $200 million thresholds and sharing arrangements as discussed on page 24, under the header "Corteva Separation Agreement."
[3]	The company has recorded an indemnification asset related to these accruals, including $40 million related to the Superfund sites.
[4]	Represents liabilities that are subject to the $150 million thresholds and sharing agreements as discussed on page 23, under the header "Chemours / Performance Chemicals."

Stockholders' Equity Common Stock (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Aug. 05, 2021	Jul. 30, 2021	Dec. 31, 2020	Jun. 26, 2019
Class of Stock [Line Items]
Common Stock, Par Value	$ 0.01	$ 0.01	$ 0.01	$ 0.01		$ 0.01	$ 0.01
Repurchase of Common Stock			$ 750	$ 83
2019 Share Buyback Plan
Class of Stock [Line Items]
Stock Repurchased and Retired During Period, Shares	3,408	1,160	15,378	3,025
Stock Repurchase Program, Authorized Amount								$ 1,000
Repurchase of Common Stock	$ 150	$ 33	$ 700	$ 83
2021 Stock Repurchase Program
Class of Stock [Line Items]
Stock Repurchased and Retired During Period, Shares	1,167
Stock Repurchase Program, Authorized Amount					$ 1,500
Repurchase of Common Stock	$ 50
Corteva [Member]
Class of Stock [Line Items]
Common Stock, Par Value	$ 0.01		$ 0.01		$ 0.01

Stockholders' Equity Noncontrolling interests (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Noncontrolling Interest [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners		46.50%
Payments for acquisition of subsidiary's interest from the non-controlling Interests	$ 0	$ (60)

Stockholders' Equity Preferred Stock (Details) - EID [Member] - USD ($)	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020
$4.50 Series Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized	23,000,000	23,000,000	23,000,000
Preferred Stock, Shares Issued	1,673,000	1,673,000	1,673,000
Preferred Stock, Redemption Amount	$ 120	$ 120	$ 120
$3.50 Series Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized	23,000,000	23,000,000	23,000,000
Preferred Stock, Shares Issued	700,000	700,000	700,000
Preferred Stock, Redemption Amount	$ 102	$ 102	$ 102
Corteva [Member]
Class of Stock [Line Items]
Ownership interest in an entity	100.00%

Stockholders' Equity Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2021

Jun. 30, 2021

Mar. 31, 2021

Sep. 30, 2020

Jun. 30, 2020

Mar. 31, 2020

Sep. 30, 2021

Sep. 30, 2020

Dec. 31, 2020

Dec. 31, 2019

Beginning Balance

$ 25,625

$ 24,778

$ 25,063

$ 24,801

$ 24,079

$ 24,555

$ 25,063

$ 24,555

Amounts Reclassified from Accumulated Other Comprehensive Loss

(141)

(17)

(444)

Accumulated Other Comprehensive Income (Loss), Net of Tax

(400)

122

(477)

(663)

(755)

(526)

Ending Balance

24,979

25,625

24,778

24,346

24,801

24,079

24,979

24,346

(3,645)

(3,796)

(3,645)

(3,796)

$ (2,890)

Pension Plan

Accumulated Other Comprehensive Income (Loss) [Line Items]

Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax

(6)

(10)

Amounts Reclassified from Accumulated Other Comprehensive Loss

Accumulated Other Comprehensive Income (Loss), Net of Tax

(6)

(1,407)

(1,253)

(1,407)

(1,253)

(1,433)

$ (1,247)

Other Benefit Plans

Accumulated Other Comprehensive Income (Loss) [Line Items]

Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax

Amounts Reclassified from Accumulated Other Comprehensive Loss

(475)

Accumulated Other Comprehensive Income (Loss), Net of Tax

(474)

116

(78)

116

(78)

590

(81)

Cumulative Translation Adjustment

Accumulated Other Comprehensive Income (Loss) [Line Items]

Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax

^[1]

(424)

(507)

Amounts Reclassified from Accumulated Other Comprehensive Loss

Accumulated Other Comprehensive Income (Loss), Net of Tax

(424)

(507)

(2,394)

(2,451)

(2,394)

(2,451)

(1,970)

(1,944)

Derivative Instruments

Accumulated Other Comprehensive Income (Loss) [Line Items]

Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax

115

(23)

Amounts Reclassified from Accumulated Other Comprehensive Loss

(19)

(8)

Accumulated Other Comprehensive Income (Loss), Net of Tax

107

(16)

(14)

(67)

Unrealized Gain (loss) on Investments

Accumulated Other Comprehensive Income (Loss) [Line Items]

Beginning Balance

(10)

Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax

Amounts Reclassified from Accumulated Other Comprehensive Loss

^[2]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Ending Balance

Total

Beginning Balance

(3,245)

(3,367)

(2,890)

(3,845)

(3,933)

(3,270)

(2,890)

(3,270)

Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax

(311)

(538)

Amounts Reclassified from Accumulated Other Comprehensive Loss

(444)

Accumulated Other Comprehensive Income (Loss), Net of Tax

(400)

122

(477)

(663)

(755)

(526)

Ending Balance

(3,645)

$ (3,245)

$ (3,367)

(3,796)

$ (3,845)

$ (3,933)

(3,645)

(3,796)

$ (3,645)

$ (3,796)

$ (3,645)

$ (3,796)

$ (2,890)

$ (3,270)

[1]

The cumulative translation adjustment loss for the nine months ended September 30, 2021 was primarily driven by strengthening of the USD against the European Euro ("EUR"), Swiss Franc ("CHF") and Brazilian Real ("BRL"). The cumulative translation adjustment loss for the nine months ended September 30, 2020 was primarily driven by strengthening of the USD against the Brazilian Real ("BRL") and the South African Rand ("ZAR") against the USD.

[2]

Reflected in other income - net in the interim Consolidated Statements of Operations.

Stockholders' Equity Tax Benefit (Expense) on Net Activity (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	$ 36	$ 4	$ 103	$ 3
Pension Plan
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	(3)	0	(8)	(3)
Other Benefit Plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	51	0	148	0
Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	$ (12)	$ 4	$ (37)	$ 6

Amount of tax expense (benefit) allocated to other comprehensive income (loss).

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120385591&loc=d3e39076-109324

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 20
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Stockholders' Equity Reclassifications out of AOCI (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2021

Sep. 30, 2020

Sep. 30, 2021

Sep. 30, 2020

Amounts Reclassified from Accumulated Other Comprehensive Loss

$ (141)

$ (17)

$ (444)

$ 12

Other Benefit Plans

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Amortization of Prior Service Benefit

(231)

^[1],[2]

(692)

Pension Plan

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Amounts Reclassified from Accumulated Other Comprehensive Loss

Other Benefit Plans

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Amounts Reclassified from Accumulated Other Comprehensive Loss

(475)

Derivative Instruments

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax

^[3]

(22)

^[3]

(9)

Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax

(1)

^[4]

(6)

Amounts Reclassified from Accumulated Other Comprehensive Loss

(19)

(8)

Actuarial (Gains) Losses | Pension Plan

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax

^[1],[2]

Actuarial (Gains) Losses | Other Benefit Plans

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax

^[1],[2]

Settlement Loss | Pension Plan

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax

^[1],[2]

Accumulated Defined Benefit Plans Adjustment Attributable to Parent | Pension Plan

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax

Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax

(3)

^[4]

(9)

(1)

Amounts Reclassified from Accumulated Other Comprehensive Loss

Accumulated Defined Benefit Plans Adjustment Attributable to Parent | Other Benefit Plans

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax

(208)

(623)

Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax

^[4]

148

Amounts Reclassified from Accumulated Other Comprehensive Loss

(157)

(475)

Unrealized loss on investments

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax

^[4]

Amounts Reclassified from Accumulated Other Comprehensive Loss

^[1]

Prior Service Benefit | Pension Plan

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax

(1)

Accumulated Defined Benefit Plans Adjustment, Curtailment Gain (Loss) | Other Benefit Plans

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax

$ 0

$ (1)

$ 0

[1]	Reflected in other income - net in the interim Consolidated Statements of Operations.
[2]	These accumulated other comprehensive (loss) income components are included in the computation of net periodic benefit credit of the company's pension and other benefit plans. See Note 15 - Pension Plans and Other Post Employment Benefits, for additional information.
[3]	Reflected in cost of goods sold in the interim Consolidated Statements of Operations.
[4]	Reflected in (benefit from) provision for income taxes from continuing operations in the interim Consolidated Statements of Operations.

Pension Plans and Other Post Employment Benefit Plans Components of net periodic benefit cost (credit) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service Cost	$ 7	$ 6	$ 19	$ 19
Interest Cost	91	139	273	420
Expected return on plan assets	(228)	(250)	(686)	(750)
Amortization of unrecognized loss (gain)	14	1	41	3
Amortization of Prior Service Benefit	0	0	(1)	(1)
Settlement/Curtailment Loss (Gain)	0	0	1	3
Defined Benefit Plan, Net Periodic Benefit (Credit) Cost	(116)	(104)	(353)	(306)
Other Benefit Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service Cost	1	0	1	1
Interest Cost	5	16	16	49
Amortization of unrecognized loss (gain)	23	1	70	1
Amortization of Prior Service Benefit	(231)	0	(692)	0
Defined Benefit Plan, Net Periodic Benefit (Credit) Cost	(202)	17	(606)	51
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment	$ 0	$ 0	$ (1)	$ 0

Financial Instruments Financial Instruments (Narrative) (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020
Cash Equivalents [Member]
Schedule of Held-to-maturity Securities [Line Items]
Held-to-maturity securities	$ 2,108	$ 2,511	$ 1,986
Available - for- sale securities		226
Marketable Securities [Member]
Schedule of Held-to-maturity Securities [Line Items]
Held-to-maturity securities	$ 103	$ 43	$ 152

Financial Instruments Notional Amounts (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020
Designated as Hedging Instrument [Member] \| Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	$ 1,227	$ 1,164	$ 770
Designated as Hedging Instrument [Member] \| Commodity Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	262	383	51
Not Designated as Hedging Instrument [Member] \| Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	1,164	647	924
Not Designated as Hedging Instrument [Member] \| Commodity Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	$ 7	$ 0	$ 0

Financial Instruments Cash Flow Hedges Included in AOCI (Details) € in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2021 EUR (€)	Dec. 31, 2020 USD ($)
Designated as Hedging Instrument [Member] \| Commodity Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Remaining Maturity			2 years
Beginning Balance	$ 73	$ (16)	$ (16)	$ 2
Additions and revaluations of derivatives designated as cash flow hedges	(10)	10	93	(34)
Clearance of hedge results to earnings	(4)	(2)	(18)	24
Ending Balance	59	(8)	59	(8)
After-tax net gain (loss) to be reclassified from AOCL into earnings over the next twelve months			(50)
Derivative, Notional Amount	262	51	$ 262	51		$ 383
Designated as Hedging Instrument [Member] \| Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Remaining Maturity			2 years
Beginning Balance	(21)	19	$ (17)	0
Additions and revaluations of derivatives designated as cash flow hedges	8	4	3	23
Clearance of hedge results to earnings	9	(17)	10	(17)
Ending Balance	(4)	6	(4)	6
After-tax net gain (loss) to be reclassified from AOCL into earnings over the next twelve months			11
Derivative, Notional Amount	$ 1,227	$ 770	$ 1,227	$ 770		$ 1,164
Net Investment Hedging [Member] \| Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount \| €					€ 450

Financial Instruments Fair Value of Derivatives (Details) - USD ($)
$ in Millions

Sep. 30, 2021

Dec. 31, 2020

Sep. 30, 2020

Derivative Instruments, Gain (Loss) [Line Items]

Derivative Asset, Counterparty and Cash Collateral Netting

$ 57

$ 55

$ 126

^[1]

(23)

(40)

(75)

Derivative Liability, Counterparty and Cash Collateral Netting

135

^[1]

(23)

(40)

(69)

Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Other Current Assets [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Derivative Asset, Counterparty and Cash Collateral Netting

^[1]

Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Accrued and Other Current Liabilities [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Derivative Liability, Counterparty and Cash Collateral Netting

^[1]

Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Other Current Assets [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Derivative Asset, Counterparty and Cash Collateral Netting

101

^[1]

(23)

(40)

(75)

Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Accrued and Other Current Liabilities [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Derivative Liability, Counterparty and Cash Collateral Netting

^[1]

(23)

(40)

(69)

Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Other Current Assets [Member]

$ 8

$ 57

Derivative Instruments, Gain (Loss) [Line Items]

Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Accrued and Other Current Liabilities [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Derivative Instruments, Gain (Loss) [Line Items]

$ 1

[1]

Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

Financial Instruments Effect of Derivative Instruments (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2021

Sep. 30, 2020

Sep. 30, 2021

Sep. 30, 2020

Gain (Loss) on Derivative Instruments, Net, Pretax

^[1]

$ 39

$ 19

$ (25)

$ 188

Designated as Hedging Instrument [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Amount of gain (loss) recognized in Income - Pre-tax

^[2]

(2)

153

(35)

^[1]

(6)

(13)

Designated as Hedging Instrument [Member] | Net Investment Hedging [Member] | Foreign Currency Contract [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Foreign Currency Contract [Member]

^[2]

(20)

(16)

Derivative Instruments, Gain (Loss) [Line Items]

Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Foreign Currency Contract [Member] | Cost of Goods Sold

^[2]

Derivative Instruments, Gain (Loss) [Line Items]

Amount of gain (loss) recognized in Income - Pre-tax

^[1],[3]

(10)

(11)

Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Commodity Contract [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Commodity Contract [Member] | Cost of Goods Sold

^[2]

(11)

117

(46)

Derivative Instruments, Gain (Loss) [Line Items]

Amount of gain (loss) recognized in Income - Pre-tax

^[1],[3]

(32)

Not Designated as Hedging Instrument [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Amount of gain (loss) recognized in income - pre-tax

^[1]

(3)

(34)

201

Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Cost of Goods Sold

Derivative Instruments, Gain (Loss) [Line Items]

Amount of gain (loss) recognized in income - pre-tax

^[1],[3]

(16)

Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Other Income - net

Derivative Instruments, Gain (Loss) [Line Items]

Amount of gain (loss) recognized in income - pre-tax

^[1],[4]

(6)

173

Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Cost of Goods Sold

Derivative Instruments, Gain (Loss) [Line Items]

Amount of gain (loss) recognized in income - pre-tax

^[1],[3]

$ (1)

$ 0

$ (18)

$ 9

[1]	For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.
[2]	OCI is defined as other comprehensive income (loss).
[3]	Recorded in cost of goods sold in the interim Consolidated Statements of Operations.
[4]	Gain recognized in other income (expense) - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 - Supplementary Information, for additional information.

Financial Instruments- AFS Investing Results (Details) - Available-for-sale Securities $ in Millions	9 Months Ended
	Sep. 30, 2021 USD ($)
Debt Securities, Available-for-sale [Line Items]
Proceeds from sales of available-for-sale securities	$ 226
Gross realized losses	$ (7)

Fair Value Measurements (Details) - USD ($)
$ in Millions

Sep. 30, 2021

Dec. 31, 2020

Sep. 30, 2020

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Derivative Asset

$ 57

$ 55

$ 126

Derivative Liability

135

Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Equity Securities,

^[1]

Assets at Fair Value

226

Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 | US Treasury Securities

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Debt Securities, Available-for-sale

^[2]

226

Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Assets at Fair Value

160

278

Liabilities at Fair Value

135

Marketable Securities

103

152

Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Foreign Currency Contract [Member]

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Derivative Asset

^[3]

125

Derivative Liability

$ 40

^[3]

$ 135

^[3]

Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Commodity Contract [Member]

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Derivative Asset

^[3]

Derivative Liability

^[3]

$ 1

[1]	The company's equity securities are included in other assets in the interim Consolidated Balance Sheets.
[2]	The company's investments in debt securities, which are available-for-sale, are included in "marketable securities" in the interim Consolidated Balance Sheets
[3]	See Note 16 - Financial Instruments for the classification of derivatives in the interim Consolidated Balance Sheets.3. The company's equity securities are included in other assets in the interim Consolidated Balance Sheets.

Segment Reporting Segment Information (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2021

Sep. 30, 2020

Sep. 30, 2021

Sep. 30, 2020

Dec. 31, 2020

$ 2,371

$ 1,863

$ 12,176

$ 11,010

(11)

(152)

2,420

1,932

Segment Assets

36,240

36,965

36,240

36,965

$ 36,850

Seed [Member]

738

523

7,010

6,516

(217)

(282)

1,523

1,255

Segment Assets

23,701

^[1]

24,372

^[1]

23,701

^[1]

24,372

^[1]

23,751

Crop Protection [Member]

1,633

1,340

5,166

4,494

206

130

897

677

Segment Assets

$ 12,539

^[1]

$ 12,593

^[1]

$ 12,539

^[1]

$ 12,593

^[1]

$ 13,099

[1]	Segment assets at December 31, 2020 were $23,751 million and $13,099 million for Seed and Crop Protection, respectively.

Segment Reporting Segment Reconciliation (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2021

Sep. 30, 2020

Sep. 30, 2021

Sep. 30, 2020

Income (loss) from continuing operations after income taxes

$ 36

$ (390)

$ 1,667

$ 657

(Benefit from) provision for income taxes on continuing operations

(28)

(117)

434

Income from continuing operations before income taxes

(507)

2,101

745

Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges

^[1]

(67)

(47)

(127)

(21)

214

351

106

Non-operating pension and other post employment benefit credit

(11)

(152)

2,420

1,932

^[2]

326

979

275

(Benefit from) provision for income taxes on continuing operations

(30)

(122)

425

Income from continuing operations before income taxes

(3)

(526)

2,062

663

309

285

926

868

Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges

117

^[3]

(8)

(3)

^[3]

(21)

214

351

106

(11)

(152)

2,420

1,932

309

285

926

868

(19)

(11)

(58)

(38)

Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges

(2)

127

^[4]

(3)

Non-operating pension and other post employment benefit credit

(49)

(214)

(351)

(315)

(73)

(941)

(237)

Segment Reconciling Items [Member] | EID [Member]

(19)

(11)

(58)

(38)

$ (2)

$ 67

$ 47

$ 127

[1]	Includes net pre-tax exchange losses of $(16) million and $(53) million associated with the devaluation of the Argentine peso for the three and nine months ended September 30, 2021, respectively, and $(26) million and $(56) million for the three and nine months ended September 30, 2020, respectively.
[2]	Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement loss).
[3]	Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. For the three and six months ended September 30, 2020, the unrealized mark-to-market (loss) gain was $(8) million and $19 million, respectively.
[4]	Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. For the three and nine months ended September 30, 2020, the unrealized mark-to-market (loss) gain was $(8) million and $19 million, respectively. Refer to page 57 for further discussion of the company’s Non-GAAP financial measures.

Segment Reporting Segment Asset Reconciliation (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020
Segment Reporting [Abstract]
Segment Assets	$ 36,240	$ 36,850	$ 36,965
Corporate Assets	4,882	5,799	4,725
Total Assets	$ 41,122	$ 42,649	$ 41,690

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Segment Reporting Significant Items (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2021

Sep. 30, 2020

Sep. 30, 2021

Sep. 30, 2020

$ 26

$ 49

$ 261

$ 298

(21)

214

351

^[1]

(67)

(47)

(127)

Argentine Peso Devaluation [Member] | Hedging Program [Member]

(6)

173

(16)

(26)

(53)

(56)

^[2]

(26)

(49)

(261)

(298)

Loss on Divestiture

^[3]

(53)

(49)

(214)

(351)

Segment Reconciling Items [Member] | Seed [Member]

(2)

127

^[2]

(9)

(145)

(154)

Segment Reconciling Items [Member] | Crop Protection [Member]

(9)

(98)

(154)

^[2]

(8)

(40)

(51)

(98)

Loss on Divestiture

(53)

Segment Reconciling Items [Member] | Crop Protection [Member] | Sale of JV [Member]

(8)

(40)

(51)

(151)

Segment Reconciling Items [Member] | Corporate

Loss on Divestiture

^[3]

(53)

^[2]

(9)

(65)

(46)

$ (9)

$ 0

$ (65)

$ (46)

[1]	Includes net pre-tax exchange losses of $(16) million and $(53) million associated with the devaluation of the Argentine peso for the three and nine months ended September 30, 2021, respectively, and $(26) million and $(56) million for the three and nine months ended September 30, 2020, respectively.
[2]	Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements for additional information.
[3]	Includes a loss recorded in other income - net related to the sale of the La Porte site.

EID - Basis of Presentation Narrative (Details) - $ / shares	9 Months Ended
	Sep. 30, 2021	Aug. 05, 2021	Jul. 30, 2021	Dec. 31, 2020	Sep. 30, 2020
EID [Member]
Common Stock, Shares, Outstanding	200			200	200
Common Stock, Par Value	$ 0.30		$ 0.30	$ 0.30	$ 0.30
Common Stock, Shares, Outstanding	730,267,000			743,458,000	747,492,000
Common Stock, Par Value	$ 0.01		$ 0.01	$ 0.01	$ 0.01
Corteva [Member] \| EID [Member]
Ownership interest in an entity	100.00%
Corteva [Member]
Common Stock, Par Value	$ 0.01	$ 0.01

EID - Related Party Transactions (Details) - EID [Member] - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Related Party Transaction [Line Items]
Long Term Debt - Related Party	$ 2,443	$ 3,712	$ 2,443	$ 3,712	$ 3,459
Corteva [Member]
Related Party Transaction [Line Items]
Debt, Weighted Average Interest Rate	1.52%	1.80%	1.52%	1.80%	1.62%
Interest Expense, Related Party	$ 11	$ 19	$ 39	$ 82
Corteva [Member] \| Accrued and Other Current Liabilities [Member]
Related Party Transaction [Line Items]
CTVA Related Party Liability	61	110	61	110	$ 92
Corteva [Member] \| Other noncurrent obligations
Related Party Transaction [Line Items]
CTVA Related Party Liability	$ 90	$ 84	$ 90	$ 84	$ 92

EID Segment FN Segment reconciliation (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2021

Sep. 30, 2020

Sep. 30, 2021

Sep. 30, 2020

(Benefit from) provision for income taxes on continuing operations

$ (28)

$ (117)

$ 434

$ 88

Income from continuing operations before income taxes

(507)

2,101

745

^[1]

(67)

(47)

(127)

(21)

214

351

106

Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges

(11)

(152)

2,420

1,932

Income from Continuing Operations After Taxes

(404)

1,637

595

(Benefit from) provision for income taxes on continuing operations

(30)

(122)

425

Income from continuing operations before income taxes

(3)

(526)

2,062

663

309

285

926

868

Non-operating benefits - net

117

(315)

(73)

(941)

(237)

(21)

214

351

106

Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges

(11)

(152)

2,420

1,932

^[2]

(8)

(3)

^[2]

309

285

926

868

(19)

(11)

(58)

(38)

(2)

127

Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges

(49)

(214)

(351)

^[3]

(3)

Segment Reconciling Items [Member] | EID [Member]

(19)

(11)

(58)

(38)

(2)

127

Hedging Program [Member] | Argentine Peso Devaluation [Member]

(6)

173

Corporate | Segment Reconciling Items [Member]

(16)

(26)

(53)

(56)

(9)

(65)

(46)

Crop Protection [Member]

Crop Protection [Member] | Segment Reconciling Items [Member]

206

130

897

677

$ (8)

$ (40)

$ (51)

$ (151)

[1]	Includes net pre-tax exchange losses of $(16) million and $(53) million associated with the devaluation of the Argentine peso for the three and nine months ended September 30, 2021, respectively, and $(26) million and $(56) million for the three and nine months ended September 30, 2020, respectively.
[2]	Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. For the three and six months ended September 30, 2020, the unrealized mark-to-market (loss) gain was $(8) million and $19 million, respectively.
[3]	Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. For the three and nine months ended September 30, 2020, the unrealized mark-to-market (loss) gain was $(8) million and $19 million, respectively. Refer to page 57 for further discussion of the company’s Non-GAAP financial measures.

EID Segment FN Segment Asset Reconciliation (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020
EID [Member]
Segment Reporting Information [Line Items]
Total Assets	$ 41,122	$ 42,649	$ 41,690
Segment Assets	36,240	36,850	36,965
Corporate Assets	4,882	5,799	4,725
Total Assets	$ 41,122	$ 42,649	$ 41,690